SE443558B - PROCEDURE FOR THE PREPARATION OF AMINOAL REFRIGERATIVE SUBSTANCES WITH PHARMACEUTICAL EFFECT - Google Patents
PROCEDURE FOR THE PREPARATION OF AMINOAL REFRIGERATIVE SUBSTANCES WITH PHARMACEUTICAL EFFECTInfo
- Publication number
- SE443558B SE443558B SE7805591A SE7805591A SE443558B SE 443558 B SE443558 B SE 443558B SE 7805591 A SE7805591 A SE 7805591A SE 7805591 A SE7805591 A SE 7805591A SE 443558 B SE443558 B SE 443558B
- Authority
- SE
- Sweden
- Prior art keywords
- group
- formula
- compound
- methyl
- silica gel
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims description 8
- 230000004526 pharmaceutical effect Effects 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 100
- -1 1-pyrrolidinylmethyl Chemical group 0.000 claims description 81
- 150000001412 amines Chemical class 0.000 claims description 27
- 229910052757 nitrogen Inorganic materials 0.000 claims description 17
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 5
- 150000002540 isothiocyanates Chemical class 0.000 claims description 5
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 239000012948 isocyanate Substances 0.000 claims description 4
- 150000002513 isocyanates Chemical class 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 239000012458 free base Substances 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 150000003141 primary amines Chemical class 0.000 claims description 3
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims description 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 2
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical group O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 claims description 2
- 101100439663 Arabidopsis thaliana CHR7 gene Proteins 0.000 claims 2
- 101100294106 Caenorhabditis elegans nhr-3 gene Proteins 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 126
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 114
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 111
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 77
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 76
- 239000000741 silica gel Substances 0.000 description 70
- 229910002027 silica gel Inorganic materials 0.000 description 70
- 229910021529 ammonia Inorganic materials 0.000 description 63
- 238000004809 thin layer chromatography Methods 0.000 description 59
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 36
- 239000000243 solution Substances 0.000 description 27
- 238000002844 melting Methods 0.000 description 26
- 230000008018 melting Effects 0.000 description 26
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 23
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- 239000000203 mixture Substances 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- 238000009835 boiling Methods 0.000 description 19
- 150000004985 diamines Chemical class 0.000 description 17
- 239000003921 oil Substances 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 14
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- 239000000706 filtrate Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- 239000001257 hydrogen Substances 0.000 description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 239000000155 melt Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 230000028327 secretion Effects 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- ANFZRGMDGDYNGA-UHFFFAOYSA-N ethyl acetate;propan-2-ol Chemical compound CC(C)O.CCOC(C)=O ANFZRGMDGDYNGA-UHFFFAOYSA-N 0.000 description 7
- 210000004051 gastric juice Anatomy 0.000 description 7
- 239000000543 intermediate Substances 0.000 description 7
- 239000012280 lithium aluminium hydride Substances 0.000 description 7
- IAVREABSGIHHMO-UHFFFAOYSA-N 3-hydroxybenzaldehyde Chemical compound OC1=CC=CC(C=O)=C1 IAVREABSGIHHMO-UHFFFAOYSA-N 0.000 description 6
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 6
- 229910052717 sulfur Chemical group 0.000 description 6
- 239000011593 sulfur Chemical group 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 239000012230 colorless oil Substances 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 235000019502 Orange oil Nutrition 0.000 description 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 125000003172 aldehyde group Chemical group 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 150000004702 methyl esters Chemical class 0.000 description 4
- 239000010502 orange oil Substances 0.000 description 4
- 150000003891 oxalate salts Chemical class 0.000 description 4
- 230000010412 perfusion Effects 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 239000012312 sodium hydride Substances 0.000 description 4
- 229910000104 sodium hydride Inorganic materials 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- NXGHEDHQXXXTTP-UHFFFAOYSA-N 1,1-bis(methylsulfanyl)-2-nitroethene Chemical group CSC(SC)=C[N+]([O-])=O NXGHEDHQXXXTTP-UHFFFAOYSA-N 0.000 description 3
- VKJCJJYNVIYVQR-UHFFFAOYSA-N 2-(3-bromopropyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCCBr)C(=O)C2=C1 VKJCJJYNVIYVQR-UHFFFAOYSA-N 0.000 description 3
- OGMADIBCHLQMIP-UHFFFAOYSA-N 2-aminoethanethiol;hydron;chloride Chemical compound Cl.NCCS OGMADIBCHLQMIP-UHFFFAOYSA-N 0.000 description 3
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- REPYKJUHULFZIZ-UHFFFAOYSA-N OC(=O)C(O)=O.OC(=O)C(O)=O.CNCC1=CC=CC(OCCCN)=C1 Chemical compound OC(=O)C(O)=O.OC(=O)C(O)=O.CNCC1=CC=CC(OCCCN)=C1 REPYKJUHULFZIZ-UHFFFAOYSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- VUUSSTMNTMTMID-UHFFFAOYSA-N [3-[(dimethylamino)methyl]phenyl]methanol Chemical compound CN(C)CC1=CC=CC(CO)=C1 VUUSSTMNTMTMID-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 229940097265 cysteamine hydrochloride Drugs 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 3
- 229960001340 histamine Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 125000002560 nitrile group Chemical group 0.000 description 3
- 125000005544 phthalimido group Chemical group 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- HXMWGMZZNGHVPQ-UHFFFAOYSA-N 3-[(dimethylamino)methyl]phenol Chemical compound CN(C)CC1=CC=CC(O)=C1 HXMWGMZZNGHVPQ-UHFFFAOYSA-N 0.000 description 2
- ZEQMMXMSZSMEND-UHFFFAOYSA-N 3-[3-[(dimethylamino)methyl]phenoxy]propan-1-amine Chemical compound CN(C)CC1=CC=CC(OCCCN)=C1 ZEQMMXMSZSMEND-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 2
- 241001631457 Cannula Species 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- LGDSHSYDSCRFAB-UHFFFAOYSA-N Methyl isothiocyanate Chemical compound CN=C=S LGDSHSYDSCRFAB-UHFFFAOYSA-N 0.000 description 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- NDKBVBUGCNGSJJ-UHFFFAOYSA-M benzyltrimethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)CC1=CC=CC=C1 NDKBVBUGCNGSJJ-UHFFFAOYSA-M 0.000 description 2
- 125000005392 carboxamide group Chemical group NC(=O)* 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
- MHYCRLGKOZWVEF-UHFFFAOYSA-N ethyl acetate;hydrate Chemical compound O.CCOC(C)=O MHYCRLGKOZWVEF-UHFFFAOYSA-N 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- MHGGQXIPBPGZFB-UHFFFAOYSA-N methyl n-cyano-n'-methylcarbamimidothioate Chemical compound CSC(=NC)NC#N MHGGQXIPBPGZFB-UHFFFAOYSA-N 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 2
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 125000004055 thiomethyl group Chemical group [H]SC([H])([H])* 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- AUKYPBVDCXDXPI-UHFFFAOYSA-N 2-[3-[(dimethylamino)methyl]phenoxy]ethanamine Chemical compound CN(C)CC1=CC=CC(OCCN)=C1 AUKYPBVDCXDXPI-UHFFFAOYSA-N 0.000 description 1
- KEWLVUBYGUZFKX-UHFFFAOYSA-N 2-ethylguanidine Chemical compound CCNC(N)=N KEWLVUBYGUZFKX-UHFFFAOYSA-N 0.000 description 1
- ASUDFOJKTJLAIK-UHFFFAOYSA-N 2-methoxyethanamine Chemical compound COCCN ASUDFOJKTJLAIK-UHFFFAOYSA-N 0.000 description 1
- YKPIQPFENMASFE-UHFFFAOYSA-N 2-phenoxy-2-phenylpropanenitrile Chemical compound CC(C1=CC=CC=C1)(OC1=CC=CC=C1)C#N YKPIQPFENMASFE-UHFFFAOYSA-N 0.000 description 1
- AGYXIUAGBLMBGV-UHFFFAOYSA-N 3,5-dimethylpyrazole-1-carboximidamide;nitric acid Chemical compound O[N+]([O-])=O.CC=1C=C(C)N(C(N)=N)N=1 AGYXIUAGBLMBGV-UHFFFAOYSA-N 0.000 description 1
- WBZUWTTYEQKRHF-UHFFFAOYSA-N 3-(dimethylcarbamoyl)benzoic acid Chemical compound CN(C)C(=O)C1=CC=CC(C(O)=O)=C1 WBZUWTTYEQKRHF-UHFFFAOYSA-N 0.000 description 1
- TWSPCURRUHDKQY-UHFFFAOYSA-N 3-[3-(2-aminoethoxy)phenyl]-N,N-dimethylpropan-1-amine Chemical compound NCCOC=1C=C(C=CC=1)CCCN(C)C TWSPCURRUHDKQY-UHFFFAOYSA-N 0.000 description 1
- COWQCIREVPJAME-UHFFFAOYSA-N 3-[3-(3-aminopropoxy)phenyl]-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCC1=CC=CC(OCCCN)=C1 COWQCIREVPJAME-UHFFFAOYSA-N 0.000 description 1
- UHLNNZTZHPWKHF-UHFFFAOYSA-N 3-[3-[(dimethylamino)methyl]phenyl]propan-1-ol Chemical compound CN(C)CC1=CC=CC(CCCO)=C1 UHLNNZTZHPWKHF-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- FRSIONXERVTUIB-UHFFFAOYSA-N 4-[3-[(dimethylamino)methyl]phenoxy]butan-1-amine Chemical compound CN(C)CC1=CC=CC(OCCCCN)=C1 FRSIONXERVTUIB-UHFFFAOYSA-N 0.000 description 1
- NCYRKHFDTLAITF-UHFFFAOYSA-N 4-[3-[(dimethylamino)methyl]phenyl]butan-1-amine Chemical compound CN(C)CC1=CC=CC(CCCCN)=C1 NCYRKHFDTLAITF-UHFFFAOYSA-N 0.000 description 1
- VMFHMHLJZKBWRY-UHFFFAOYSA-N 4-[3-[2-(dimethylamino)ethyl]phenoxy]butan-1-amine Chemical compound NCCCCOC=1C=C(C=CC=1)CCN(C)C VMFHMHLJZKBWRY-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- XDCNDYRUTSITJB-UHFFFAOYSA-N C(C(=O)O)(=O)O.C(C(=O)O)(=O)O.NCCCOC1=CC=C(C=C1)CN(C)C Chemical compound C(C(=O)O)(=O)O.C(C(=O)O)(=O)O.NCCCOC1=CC=C(C=C1)CN(C)C XDCNDYRUTSITJB-UHFFFAOYSA-N 0.000 description 1
- QQXAXJQNYQMPOR-UHFFFAOYSA-N C(CC)C(=C(N)N)[N+](=O)[O-] Chemical compound C(CC)C(=C(N)N)[N+](=O)[O-] QQXAXJQNYQMPOR-UHFFFAOYSA-N 0.000 description 1
- JGLMVXWAHNTPRF-CMDGGOBGSA-N CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O Chemical compound CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O JGLMVXWAHNTPRF-CMDGGOBGSA-N 0.000 description 1
- 101100516554 Caenorhabditis elegans nhr-5 gene Proteins 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 101100298295 Drosophila melanogaster flfl gene Proteins 0.000 description 1
- 238000006824 Eschweiler-Clarke methylation reaction Methods 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 229920005372 Plexiglas® Polymers 0.000 description 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- KCSZGCNCOFOSQD-UHFFFAOYSA-N [2-[(dimethylamino)methyl]phenyl]methanol Chemical compound CN(C)CC1=CC=CC=C1CO KCSZGCNCOFOSQD-UHFFFAOYSA-N 0.000 description 1
- GDMUNGBYFQGLBW-UHFFFAOYSA-N [3-(methylaminomethyl)phenyl]methanol Chemical compound CNCC1=CC=CC(CO)=C1 GDMUNGBYFQGLBW-UHFFFAOYSA-N 0.000 description 1
- FZEXGKWMKMGXBI-UHFFFAOYSA-N [4-[(dimethylamino)methyl]phenyl]methanol Chemical compound CN(C)CC1=CC=C(CO)C=C1 FZEXGKWMKMGXBI-UHFFFAOYSA-N 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- WGQKYBSKWIADBV-UHFFFAOYSA-N aminomethyl benzene Natural products NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- WVRIJHGUJNXDRZ-UHFFFAOYSA-N ethane-1,1-diamine Chemical compound CC(N)N WVRIJHGUJNXDRZ-UHFFFAOYSA-N 0.000 description 1
- BDTDECDAHYOJRO-UHFFFAOYSA-N ethyl n-(sulfanylidenemethylidene)carbamate Chemical compound CCOC(=O)N=C=S BDTDECDAHYOJRO-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- BKBMACKZOSMMGT-UHFFFAOYSA-N methanol;toluene Chemical compound OC.CC1=CC=CC=C1 BKBMACKZOSMMGT-UHFFFAOYSA-N 0.000 description 1
- KSHGKHGTHNEELS-UHFFFAOYSA-N methyl 3-(dimethylcarbamoyl)benzoate Chemical compound COC(=O)C1=CC=CC(C(=O)N(C)C)=C1 KSHGKHGTHNEELS-UHFFFAOYSA-N 0.000 description 1
- YHIDWINLPJYINB-UHFFFAOYSA-N methyl 3-(methylcarbamoyl)benzoate Chemical compound CNC(=O)C1=CC=CC(C(=O)OC)=C1 YHIDWINLPJYINB-UHFFFAOYSA-N 0.000 description 1
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 1
- FLZZNZJENFNFOJ-UHFFFAOYSA-N methyl n'-nitrocarbamimidothioate Chemical compound CSC(N)=N[N+]([O-])=O FLZZNZJENFNFOJ-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- BEAVGOPNGFVGBG-UHFFFAOYSA-N n-[bis(methylsulfanyl)methylidene]methanesulfonamide Chemical compound CSC(SC)=NS(C)(=O)=O BEAVGOPNGFVGBG-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- GEVPUGOOGXGPIO-UHFFFAOYSA-N oxalic acid;dihydrate Chemical compound O.O.OC(=O)C(O)=O GEVPUGOOGXGPIO-UHFFFAOYSA-N 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 229910003445 palladium oxide Inorganic materials 0.000 description 1
- JQPTYAILLJKUCY-UHFFFAOYSA-N palladium(ii) oxide Chemical compound [O-2].[Pd+2] JQPTYAILLJKUCY-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 125000005543 phthalimide group Chemical group 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 238000003419 tautomerization reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000012485 toluene extract Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 125000005424 tosyloxy group Chemical group S(=O)(=O)(C1=CC=C(C)C=C1)O* 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/10—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/08—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
- C07C279/32—N-nitroguanidines
- C07C279/36—Substituted N-nitroguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
- C07C335/08—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Description
7805591-0 2 tecknar en väteatom, en nitrogrupp, en cyanogrupp, en lågalkylgrupp eller en lågalkylsulfonylgrupp, och R? betecknar en nitrogrupp eller en lågalkylsulfonylgrupp; där m betecknar ett heltal från 2 till 4; där n betecknar 0, 1 eller 2; och där Alk betecknar en rak eller förgrenad alkylenkedja innehållande 1-6 kolatomer. 7805591-0 2 represents a hydrogen atom, a nitro group, a cyano group, a lower alkyl group or a lower alkylsulfonyl group, and R represents a nitro group or a lower alkylsulfonyl group; where m represents an integer from 2 to 4; where n represents 0, 1 or 2; and wherein Alk represents a straight or branched alkylene chain containing 1-6 carbon atoms.
Med termen "lågalkyl" avses grupper innehållande 1-6 kolato- mer, företrädesvis 1-4 kolatomer, och med termen "lågalkenyl“ avses grupper innehållande 3-6 kolatomer.The term "lower alkyl" means groups containing 1-6 carbon atoms, preferably 1-4 carbon atoms, and the term "lower alkenyl" refers to groups containing 3-6 carbon atoms.
Föreningarna med formeln I kan uppvisa tautomeri, och formeln avses täcka alla tautomerer. När Alk betecknar en förgre- nad alkylenkedja, kan optiska isomerer förekomma, och formeln avses täcka alla diastereoisomerer och optiska enantiomerer.The compounds of formula I may exhibit tautomerism, and the formula is intended to cover all tautomers. When Alk represents a branched alkylene chain, optical isomers may be present, and the formula is intended to cover all diastereoisomers and optical enantiomers.
Ie föredragna föreningarna med formeln I är de förening- ar, där symbolerna Rl och H2 oberoende av varandra betecknar en väteatom eller en làgalkylgrupp eller tillsammans med den kväve- atom till vilken de är bundna bildar en 5- eller 6-ledad hetero- cyklisk ring; där Alk betecknar en rak alkylenkedja innehållande 1-3 kolatomer; där n betecknar 0 eller 1; där Y betecknar =S, =0, =CHN02 eller =NR6, där H6 betecknar väte, nitro, cyano eller alkylsulfonyl; där R; betecknar en väteatom, en alkylgrupp eller en alkoxialkylgrupp; och där m och X har de ovan angivna betydel- serna.The preferred compounds of formula I are those compounds in which the symbols R1 and H2 independently represent a hydrogen atom or a lower alkyl group or together with the nitrogen atom to which they are attached form a 5- or 6-membered heterocyclic ring. ; wherein Alk represents a straight alkylene chain containing 1-3 carbon atoms; where n represents 0 or 1; where Y represents = S, = O, = CHNO 2 or = NR 6, where H 6 represents hydrogen, nitro, cyano or alkylsulfonyl; where R; represents a hydrogen atom, an alkyl group or an alkoxyalkyl group; and where m and X have the meanings given above.
Man föredrager särskilt de föreningar, där sidokedjorna star i meta-ställning 1 förhållande till varandra.Particular preference is given to those compounds in which the side chains are in the meta-position 1 relative to each other.
I en föredragen_klass av föreningarna med formeln I betecknar symbolerna Bl och R2 var för sig en väteatom eller en metylgrupp, eller de bildar tillsammans med kväveatomen en pyrro- lidinring; Alk betecknar en metylengrupp; m betecknar O; Y beteck- nar =CHNO2 eller =NR6, där R6 betecknar nitro, qfimo eller metyl- sulfonyl; H3 betecknar en väteatom eller-en-metylgrupp; m beteck- nar 3 ; och X betecknar syre. __ H ,_ pp _ _ Nedan anges specifikafexempel på föredragna föreningar; med formeln I: af' _ P ^ 3' N-metyl-N'-¿ë-/ZÉ-(N,N-dimetylaminometyl)fenyl7metyltig7- etyl7-2-nitro-1,1-etendiamin; N-metyl-N'-ÅÉQ/23-(N-metylaminometyl)fenyl7metyltig7- etyl7-2-nitro-1,l-etendiamin; N-metyl-N'-[É-[É-(N,N-dimetylaminometyl)fenoxifpropyl7- 7805591-0 -2-nitro-l,l-etendiamin; N-metyl-N'-Å3-[§-(N-metylaminometyl)fenoxi7propyl7-2- -nitro-1,1-etendiamin; nN-metyl-N'-¿É-¿É-(1-pyrrolidinylmetyl)fenoxi7propyl7- -2-nitro-1,1-etendiamin; N-nitro-N'-13-ÅÉ-(N,N-dimetylaminometyl)fenoxi7propyl7- guanidin; N-eyano-N' -me cyl-N" .ß-ß- (rmr-aimetyiaminometyi) _ fenoxi7propyl7-guanidin; N-metyl-N'-[É-[É-(N,N-dimetylaminoetyl)fenoxi7propyl7- -2-nitro-l,l-etendiamin; N-metansulfonyl-N'-metyl-N"-[É-13-(N,N-dimety1am1nO_ metyl)-fenoxi7propyl7guanidin.In a preferred class of the compounds of formula I, the symbols B1 and R2 each represent a hydrogen atom or a methyl group, or together with the nitrogen atom they form a pyrrolidine ring; Alk represents a methylene group; m represents 0; Y represents = CHNO 2 or = NR 6, where R 6 represents nitro, q fi mo or methylsulfonyl; H3 represents a hydrogen atom or a methyl group; m denotes 3; and X represents oxygen. __ H, _ pp _ _ Below are specific examples of preferred compounds; of formula I: of '- P ^ 3' N-methyl-N'-β- (N, N-dimethylaminomethyl) phenyl] methyltigl-ethyl7-2-nitro-1,1-ethylenediamine; N-methyl-N'-ÅÉQ / 23- (N-methylaminomethyl) phenylmethyltig7-ethyl7-2-nitro-1,1-ethylenediamine; N-methyl-N '- [E- [E- (N, N-dimethylaminomethyl) phenoxypropyl] -2-nitro-1,1-ethenediamine; N-methyl-N'-Å3- [§- (N-methylaminomethyl) phenoxy] propyl] -2--nitro-1,1-ethenediamine; nN-methyl-N'-N-N- (1-pyrrolidinylmethyl) phenoxy] propyl--2-nitro-1,1-ethenediamine; N-nitro-N'-13-ÅE- (N, N-dimethylaminomethyl) phenoxy] propyl7-guanidine; N-eyano-N '-me cyl-N ".ß-ß- (rmr-acetylaminomethyl) -phenoxy-propyl-7-guanidine; N-methyl-N' - [É- [É- (N, N-dimethylaminoethyl) -phenoxy] -propyl7- - 2-Nitro-1,1-ethylenediamine; N-methanesulfonyl-N'-methyl-N "- [E-13- (N, N-dimethylamino] methyl) -phenoxy] propyl] guanidine.
Föreningarna med formeln I bildar fysiologiskt godtag- bara salter med oorganiska och organiska syror. Särskilt använd- bara salter är hydroklorider, hydrobromider och sulfater; acetater maleater och fumarater. Föreningarna kan även bilda hydrat.The compounds of formula I form physiologically acceptable salts with inorganic and organic acids. Particularly useful salts are hydrochlorides, hydrobromides and sulfates; malate acetates and fumarates. The compounds may also form hydrates.
Föreningarna med formeln I kan administreras oralt, top- iskt eller parenteralt, eller de kan administreras i form av suppositorier. Företrädesvis användes oral administrering. Före- ningarna kan användas antingen i form av bas eller i form av fysio logiskt godtagbart salt. Föreningarna blandas vanligen med farma- ceutiskt godtagbara bärare eller utspädningsmedel under bildning av farmaceutiska kompositioner. C Föreningarna med formeln I kan administreras i kombina- tion med andra aktiva ämnen, t.ex. konventionella antihistaminer.The compounds of formula I may be administered orally, topically or parenterally, or they may be administered in the form of suppositories. Preferably, oral administration is used. The compounds can be used either in the form of base or in the form of physiologically acceptable salt. The compounds are usually mixed with pharmaceutically acceptable carriers or diluents to form pharmaceutical compositions. C The compounds of formula I may be administered in combination with other active substances, e.g. conventional antihistamines.
För oral administrering har de farmaceutiska kompositionerna lämp- ligen formen av kapslar eller tabletter, vilka kan vara tabletter med lång utsöndringstid. Kompositionerna kan också har formen av drageer eller föreligga i form av sirap. Såsom exempel på lämp- liga kompositioner för lokal administrering kan man nämna salvor, tinkturer, krämer, pulverpreparat och spraypreparat.For oral administration, the pharmaceutical compositions are suitably in the form of capsules or tablets, which may be long-acting tablets. The compositions may also be in the form of dragees or in the form of syrups. Examples of suitable compositions for topical administration are ointments, tinctures, creams, powders and sprays.
En lämplig dos vid oral administrering är från 10 mg till 2 g per dygn, vanligen i form av doseringsenheter innehall- ande 2-200 mg aktiv förening per doseringsenhet. Parenteral ad- ministrering kan ske genom intermittenta injektioner eller genom kontinuerlig infusion. Injektionslösningar kan innehålla fràn 1 till 100 mg aktiv beståndsdel per ml.A suitable dose for oral administration is from 10 mg to 2 g per day, usually in the form of dosage units containing 2-200 mg of active compound per dosage unit. Parenteral administration can be by intermittent injections or by continuous infusion. Injection solutions may contain from 1 to 100 mg of active ingredient per ml.
För lokalt anbringande kan man anwánda spraypreparafi, 7805591-Û salvor, krämer eller tinkturer. Dessa kompositioner innehåller en verksam mängd av den aktiva beståndsdelen, t.ex. av storleksord- ningen l,5-2 viktprocent, räknat pà kompositionens totala vikt.For topical application, you can use spray preparations fi, 7805591-Û ointments, creams or tinctures. These compositions contain an effective amount of the active ingredient, e.g. of the order of 1, 5-2% by weight, calculated on the total weight of the composition.
De ovan beskrivna kompositionerna kan användas såväl vid humanterapi som vid veterinärterapi.The compositions described above can be used in both human therapy and veterinary therapy.
Föreningarna med formeln I kan enligt uppfinningen fran- ställas genom att en primär amin med formeln: R NAlk 1 \ / .The compounds of formula I can be prepared according to the invention by a primary amine of the formula: R NAlk 1 \ /.
Bg \\2äÉš::>--(cH2)nx(cH2)mNH2 (II) där R1, R2, Alk, X, n och m har de ovan angivna betydelserna, omsättes med en förening som kan införa gruppen -CNHR3 , ll där R; och Y har de ovan angivna betydelserna.Bg \\ 2äÉš ::> - (cH2) nx (cH2) mNH2 (II) where R1, R2, Alk, X, n and m have the meanings given above, are reacted with a compound which can introduce the group -CNHR3, II where R; and Y has the meanings given above.
Föreningar som kan införa gruppen -¶NHR5 är isocyanat- Y er RENCO, isotiocyanater RBNCS och föreningar med formeln: P NHR \C/ Eg H ' Q där Q betecknar en grupp ÄNR6 eller =CHR7, och P betecknar en avspjälkbar grupp, såsom en halogenatom, en tiometylgrupp, en 3,5-dimetylpyrazolylgrupp eller en alkoxigrupp, företrädesvis en (III) tiometylgrupp.Compounds which can introduce the group -¶NHR 5 are isocyanate- Y er RENCO, isothiocyanates RBNCS and compounds of the formula: P NHR \ C / Eg H 'Q where Q represents a group ÄNR 6 or = CHR 7, and P represents a leaving group, such as a halogen atom, a thiomethyl group, a 3,5-dimethylpyrazolyl group or an alkoxy group, preferably a (III) thiomethyl group.
Reaktionen med ett isocyanat eller isotiocyanat kan genomföras genom att aminen med formeln II och isocyanatet eller isotiocyanatet får stå i ett lösningsmedel, såsom acetonitril.The reaction with an isocyanate or isothiocyanate can be carried out by allowing the amine of formula II and the isocyanate or isothiocyanate to stand in a solvent such as acetonitrile.
Reaktionen mellan aminen med formeln II oçn en förening med for- meln III kan genomföras genom smältning av reaktionskomponenterna vid förhöja temperatur, t.ex. 1oo-12o°c. När Q betecknar =NR6, kan reaktionen mellan aminen med formeln II och föreningen med formeln III även genomföras i ett lösningsmedel, t.ex. acetonit- ril eller etanol, vid förhöjd temperatur. När Q betecknar =CHR7, kan aminen med formeln II och föreningen med formeln III omröras 7805591-0 5 i en vattenhaltig lösning vid rumstemperatur.The reaction between the amine of formula II and a compound of formula III can be carried out by melting the reactants at elevated temperature, e.g. 100 ° C-120 ° C. When Q represents = NR 6, the reaction between the amine of formula II and the compound of formula III can also be carried out in a solvent, e.g. acetonitrile or ethanol, at elevated temperature. When Q represents = CHR 7, the amine of formula II and the compound of formula III can be stirred in an aqueous solution at room temperature.
När R2 betecknar väte, kan man använda alkalimetallcyanater och alkalimetalltiocyanater, varvid reaktionen genomföres vid förhöjd temperatur. Alternativt kan man använda organiska isocyanater och isotiocyanater, t ex etylkarbonisotiocyanatidat, varvid man i ett efterföljande steg genomför basisk hydrolys.When R 2 represents hydrogen, alkali metal cyanates and alkali metal thiocyanates can be used, the reaction being carried out at elevated temperature. Alternatively, organic isocyanates and isothiocyanates can be used, for example ethyl carbonisothiocyanatidate, basic hydrolysis being carried out in a subsequent step.
Enligt en alternativ metod omsättes aminen med formeln II med P g P' \\\\fi//// (IV) en förening med formeln: där P och Q har de ovan angivna betydelserna, och P' har samma bety- delse som P, varvid P' dessutom kan beteckna en grupp -§-A , där A ' _ 0 betecknar en lågalkylgrupp, t ex metyl, när Q betecknar =CHNO2.According to an alternative method, the amine of formula II is reacted with P g P '\\\\ fi //// (IV) a compound of the formula: wherein P and Q have the meanings given above, and P' has the same meaning as P, wherein P 'may also represent a group -§-A, where A' - 0 represents a lower alkyl group, eg methyl, when Q represents = CHNO2.
Den resulterande föreningen med formeln: R1 /I NA1k // 2 . g (cH2)nr(cn2)mNHg-P (V) Q R omsättes sedan med en amin R3NH2 till bildning av en förening med for- meln I. Båda reaktionsstegen kan genomföras i ett lösningsmedel, t ex etanol eller acetonitril, vid en temperatur mellan rumstemperatur och återflödestemperatur. Föreningarna med formeln V är nya mellanproduk- ter.The resulting compound of the formula: R1 / I NA1k // 2. g (cH2) nr (cn2) mNHg-P (V) QR is then reacted with an amine R3NH2 to give a compound of formula I. Both reaction steps can be carried out in a solvent, eg ethanol or acetonitrile, at a temperature between room temperature and reflux temperature. The compounds of formula V are new intermediates.
De såsom utgångsmaterial använda primära aminerna med formeln II är nya föreningar. Dessa nya mellanprodukter kan framställas enligt ett antal olika metoder, vilka beskrives nedan.The primary amines of formula II used as starting materials are new compounds. These new intermediates can be prepared according to a number of different methods, which are described below.
De aminer med formeln II, där X betecknar syre eller svavel, kan framställas utgående från föreningar med formeln: “ß šïñ/ (cH2)nxn (X) där X betecknar syre eller svavel, där n har ovan angivna betydelse, och där R8 betecknar en grupp R1R2NAlk eller en grupp som kan omvand- las till denna grupp. En förening med formeln X omsättes härvid i 7805591-0 6 närvaro av en bas, t ex natriumhydrid, med en förening med formeln: L'(CH2)mW (XI) där L' har samma betydelse som L nedan och dessutom kan beteckna en sulfonyloxigrupp, t ex metyloxi eller tosyloxi, där m har ovan angiv- na betydelse, och där W betecknar en grupp -NH2 eller en grupp som kan omvandlas till denna grupp. Om W betecknar en skyddad aminogrupp, t ex en ftalimidogrupp, kan skyddsgruppen avlägsnas i ett efterfölj- ande steg på ovan beskrivet sätt.The amines of formula II, where X represents oxygen or sulfur, can be prepared from compounds of the formula: “ß šïñ / (cH2) nxn (X) where X represents oxygen or sulfur, where n has the meaning given above, and where R8 represents a group R1R2NAlk or a group that can be converted to this group. A compound of formula X is hereby reacted in the presence of a base, eg sodium hydride, with a compound of formula: L '(CH 2) m W (XI) wherein L' has the same meaning as L below and may in addition denote a sulfonyloxy group, for example methyloxy or tosyloxy, where m has the meaning given above, and where W represents a group -NH 2 or a group which can be converted into this group. If W represents a protected amino group, for example a phthalimido group, the protecting group can be removed in a subsequent step in the manner described above.
Grupper som kan omvandlas till gruppen R1R2NAlk är aldehyd- grupper, nitrilgrupper, karboxylsyragrupper, amidgrupper och ftalimi- dogrupper. Gruppen -CHO kan t ex omvandlas genom reducerande amine- ring med användning av en amin med formeln R1R2NH. På liknande sätt kan en karboxylsyragrupp omvandlas till motsvarande syrahalid eller ester, vilken sedan kan omsättas med en amin R1R2NH, varefter den bildade amiden reduceras med t ex litiumaluminiumhydrid till bildning av en grupp R1R2NCH2-.Groups that can be converted to the group R1R2NAlk are aldehyde groups, nitrile groups, carboxylic acid groups, amide groups and phthalimide groups. The group -CHO can be converted, for example, by reducing amination using an amine of the formula R 1 R 2 NH. Similarly, a carboxylic acid group can be converted to the corresponding acid halide or ester, which can then be reacted with an amine R1R2NH, after which the amide formed is reduced with, for example, lithium aluminum hydride to form a group R1R2NCH2-.
De aminer med formeln II, där n betecknar 1 och X betecknar syre eller svavel, kan framställas genom att en förening med 7805591-Û 7 formeln VI eller VII nedan omsättes med en förening som kan införa gruppen -X(CH2)mNH2, där X betecknar syre eller svavel och m har de ovan angivna betydelserna. När man använder en förening med formeln VI, är närvaro av en bas lämplig. När en förening med formeln VII användes, genomföres reaktionen under sura betingelser.The amines of formula II, where n represents 1 and X represents oxygen or sulfur, can be prepared by reacting a compound of formula VI or VII below with a compound which can introduce the group -X (CH 2) mNH 2, where X denotes oxygen or sulfur and m has the meanings given above. When using a compound of formula VI, the presence of a base is suitable. When a compound of formula VII is used, the reaction is carried out under acidic conditions.
Rl Rl\ NAl _ NÅlk // _ R /I -ca on H2 ca L 2 2 (VI) gg g W7(VII) I ovanstående formel VI betecknar L en avspjälkbar grupp, t.ex. en halogenatom, såsom brom, eller en acyloxigrupp, såsom acetoxi.Rl Rl \ NAl _ NÅlk // _ R / I -ca on H2 ca L 2 2 (VI) gg g W7 (VII) In the above formula VI, L represents a leaving group, e.g. a halogen atom such as bromine, or an acyloxy group such as acetoxy.
De aminer med formeln II, där n betecknar 1, m betecknar 2 och X betecknar syre eller svavel, kan framställas genom att en förening med formeln X, där n betecknar 1 och X betecknar syre eller svavel,behandlas med etylenimin.The amines of formula II, where n represents 1, m represents 2 and X represents oxygen or sulfur, can be prepared by treating a compound of formula X, where n represents 1 and X represents oxygen or sulfur, with ethyleneimine.
De aminer med formeln II, där n betecknar 0, m betecknar 5 och X betecknar syre, kan framställas genom katalytísk hydrering av motsvarande nitril med formeln: “s 0(CH2)2CN (XII) t.ex. med användning av rodium på aluminiumoxid.The amines of formula II, where n represents 0, m represents 5 and X represents oxygen, can be prepared by catalytic hydrogenation of the corresponding nitrile of the formula: 's 0 (CH 2) 2 CN (XII) e.g. using rhodium on alumina.
Föreningen med formeln XII kan framställas genom att en fenol med formeln: __; \ /7--on (XIII) 7805591-0 där R9 är en grupp som kan omvandlas till gruppen RlR2NAlk, t.ex. en aldehydgrupp, omsättes med akrylnitril i närvaro av en bas, t .ex. metanolisk bensyltrimetylammoniumhydroxid .The compound of formula XII can be prepared by a phenol of the formula: __; \ / 7 - on (XIII) 7805591-0 where R9 is a group which can be converted to the group R1R2NAlk, e.g. an aldehyde group, is reacted with acrylonitrile in the presence of a base, e.g. methanolic benzyltrimethylammonium hydroxide.
De aminer med formeln II, där X betecknar en metylen- grupp, kan enligt standardmetoder framställas utgående från före- ningar med formeln: R CHECHQCOOH (XIV) där H8 t.ex. betecknar en grupp RlR2NAlk, en karboxamidgrupp eller en nitrilgrupp. En syraklorid eller en ester av en förening med formeln XIV kan t.ex. omsättas med ammoniak, varefter den re- sulterande amiden reduceras till bildning av en amin med formeln II, där X betecknar -CH2-, n betecknar 0 och m betecknar 2.The amines of formula II, where X represents a methylene group, can be prepared according to standard methods from compounds of the formula: R CHECHQCOOH (XIV) where H8 e.g. represents a group R1R2NAlk, a carboxamide group or a nitrile group. An acid chloride or an ester of a compound of formula XIV may e.g. is reacted with ammonia, after which the resulting amide is reduced to give an amine of formula II, where X represents -CH 2 -, n represents 0 and m represents 2.
Alternativt kan en förening med formeln XIV, där R8 t.ex. betecknar en grupp RlR2NAlk, en karboxamidgrupp eller en nitril~ grupp, reduceras med t.ex. litiumaluminiumhydrid till bildning av en alkohol med formeln: “i Wzxik ^ R /e a . _ cflacnecnaon , (XV) varefter denna alkohol omvandlas till en förening med formeln: Rs p _ cflzcflgcnzL' - (XVI) där R8 betecknar RlR2NA1k, och L' har den ovan angivna betydelsen.Alternatively, a compound of formula XIV, wherein R 8 may e.g. denotes a group R1R2NAlk, a carboxamide group or a nitrile group, is reduced by e.g. lithium aluminum hydride to form an alcohol of the formula: “in Wzxik ^ R / e a. (cV) acnecnaon, (XV) after which this alcohol is converted into a compound of the formula: Rs p _ c fl zc fl gcnzL '- (XVI) where R8 represents R1R2NA1k, and L' has the meaning given above.
Föreningen med formeln XVI kan sedan omsättas med ammo- niak till bildning av en amin med formeln II, där X betecknar -CH2-, n betecknar O och m betecknar 2. Om en förening med for- meln XVI omsättes med en alkalimetallcyanid, t.ex. kaliumcyanid, erhålles en förening med formeln: 7805591-Û R8 _ w- cngcngcnzcn (XVII) Denna förening kan sedan reduceras med t.ex. litiumaluminiumnyd- rid till bildning av en amin med formeln II, där X betecknar -CH2-, och summan av n och m är 3. Alternativt kan en förening med formeln XVII hydrolyseras till en förening med formeln: “s ~-cn2cH2cn2cooH (xvIII) Om syrakloriden av denna förening omsättes med ammoniak och den resulterande amiden reduceras pà ovan beskrivet sätt, erhålles en amin med formeln II, där X betecknar ~CH2-, och summan av I n-och m är 3.The compound of formula XVI can then be reacted with ammonia to give an amine of formula II, where X represents -CH 2 -, n represents O and m represents 2. If a compound of formula XVI is reacted with an alkali metal cyanide, t. ex. potassium cyanide, a compound of the formula is obtained: 7805591-Û R8 _ w- cngcngcnzcn (XVII) This compound can then be reduced by e.g. lithium aluminum hydride to form an amine of formula II, wherein X represents -CH 2 -, and the sum of n and m is 3. Alternatively, a compound of formula XVII may be hydrolyzed to a compound of the formula: "s ~ -cn2cH2cn2cooH (xvIII) If the acid chloride of this compound is reacted with ammonia and the resulting amide is reduced as described above, an amine of formula II is obtained, where X represents -CH2-, and the sum of I n- and m is 3.
De aminer med formeln II, där n betecknar O och X be- tecknar en grupp -NH-, kan framställas genom att en förening med formeln: m2 (xxx) där R9 är en grupp som kan omvandlas till en grupp R1R2NAlk, t.ex. en grupp 0 nlnanc- , omsättes med en förening med formeln XI, varefter eventuella skyddsgrupper avlägsnas och amidgruppen reduceras.The amines of formula II, where n represents O and X represents a group -NH-, can be prepared by a compound of the formula: m2 (xxx) where R9 is a group which can be converted into a group R1R2NAlk, e.g. . a group 0 nlnanc-, is reacted with a compound of formula XI, after which any protecting groups are removed and the amide group is reduced.
Utgángsföreningarna med formeln XIV kan framställas genom katalytisk reduktion av en förening med formelnzz OCH_ ___. \* / cn=cucooxi (xx) under åtföljande eller efterföljande modifiering av aldehydgruppen. 7805591-0 10 Om reduktionen t;ex. genomföres i närvaro av en amin R1R2N , kan aldehydgruppen omvandlas till en grupp RIRZNCHÉ.The starting compounds of formula XIV can be prepared by catalytic reduction of a compound of formula NZ_ ___. \ * / cn = cucooxy (xx) during concomitant or subsequent modification of the aldehyde group. 7805591-0 10 About the reduction e.g. carried out in the presence of an amine R1R2N, the aldehyde group can be converted to a group RIRZNCHÉ.
Vid de ovan beskrivna reaktionerna för framställning av aminer med formeln II föredrager man vanligen att använda mellan- produkter innehållande den önskade gruppen RlR2NAlk eller en skydda form därav, t.ex. en ftalimidogrupp. Man kan emellertid även använ- da mellanprodukter innehållande en grupp som kan omvandlas till gruppen RlR2NAlk, varvid en dylik omvandlingsbar grupp omvandlas till gruppen RlR2NAlk i något lämpligt steg av framställningsför- farandet. p Om R1 och H2 båda betecknar väte i mellanprodukter använ- da för framställning av aminer med formeln II, kan den primära aminogruppen skyddas i vilket som helst reaktionssteg, t.ex. i forn av en ftalimidogrupp, och skyddsgruppen avlägsnas i något lämpligt steg på ovan beskrivet sätt.In the above-described reactions for the preparation of amines of formula II, it is generally preferred to use intermediates containing the desired group R 1 R 2 Nlk or a protected form thereof, e.g. a phthalimido group. However, it is also possible to use intermediates containing a group which can be converted into the group R1R2NAlk, such a convertible group being converted into the group R1R2NAlk at any suitable stage of the preparation process. If R 1 and H 2 both represent hydrogen in intermediates used to prepare amines of formula II, the primary amino group may be protected in any reaction step, e.g. in the form of a phthalimido group, and the protecting group is removed in any suitable step in the manner described above.
När H1 och/eller R2 betecknm'väte 1 mellanprodukter använ- da för framställning av aminer med formeln II, kan väteatomen eller väteatomerna om så önskas omvandlas till alkyl- eller aralkylgrupp- er med användning av t.ex. en alkyl- eller aralkylhalid. När Bl och/eller R2 skall beteckna metyl, kan det vara lämpligt att genomföra en Eschweiler-Clarke-reaktion med användning av form- aldehyd och myrsyra.When H1 and / or R2 denote hydrogen 1 intermediates used to prepare amines of formula II, the hydrogen atom or atoms may, if desired, be converted into alkyl or aralkyl groups using e.g. an alkyl or aralkyl halide. When B1 and / or R2 are to represent methyl, it may be appropriate to carry out an Eschweiler-Clarke reaction using formaldehyde and formic acid.
Uppfinningen illustreras genom följande, icke begränsan- de exempel; De förberedande exemplen l-6 beskriver framställning av utgångsmaterial, exemplen A-G beskriver framställning av mellanprodukter med formeln II, och exemplen 1-9 beskriver fram- ställning av föreningar med formeln I. De i exemplen angivna tunnskiktskromatografiska mätningarna genomfördes på silikagel- plattor med tjockleken 0,25 mm monterade på en plastbärare.The invention is illustrated by the following non-limiting examples; Preparative Examples 1-6 describe the preparation of starting materials, Examples AG describe the preparation of intermediates of formula II, and Examples 1-9 describe the preparation of compounds of formula I. The thin layer chromatographic measurements given in the examples were performed on silica gel plates having a thickness of 0 , 25 mm mounted on a plastic carrier.
NMR-data anges i ï-värden.NMR data are given in ï values.
I Förberedande exempel l. 3-(l-pyrrolidinylmetylåfenol. 15,2 g natriumborhydrid sattes vill en lösning av 48,8 g 3-hydroxibensaldehyd och 66,4 ml pyrrolidin_i etanol. Efter _ 18 timmar avlägsnades etanolen, och den kvarvarande oljan sur-' gjordes med saltsyra och tvättades med etylacetat. Vattenlösning- «- en alkaliserades därefter med ammoniak och extraherades med etyl- acetat. Efter indunstning av det organiska extraktet erhöll man 21,4 g av den önskade föreningen såsom ett vitaktigt fast ämne med en smäitpunkt av 1oo-1o2°<;_ Rfe 0,48 vid vurmskiktsxæomatogra- I, 7805591-0 fi på silikagel; metanol: 0,88 ammoniak (80:1).In Preparative Example 1. 3- (1-Pyrrolidinylmethylaphenol. 15.2 g of sodium borohydride were added to a solution of 48.8 g of 3-hydroxybenzaldehyde and 66.4 ml of pyrrolidine in ethanol.) After 18 hours, the ethanol was removed and the residual oil was acidified. The aqueous solution was then alkalized with ammonia and extracted with ethyl acetate. After evaporation of the organic extract, 21.4 g of the desired compound were obtained as an off-white solid with a melting point of ethyl acetate. 100 DEG-48 DEG C. R48 0.48 on silica gel on silica gel; methanol: 0.88 ammonia (80: 1).
Förberedande exemgel 2. (a) 3-(N,N-dimetylaminometyl)bensenmetanol. (1) 3-(N,N-dimetylaminokarbonyl)bensoesyra-metyl fiåfiâš- En blandning av 88 g tionylklorid och 33 å bensen-1,3-dä -karboxylsyra-monometylester upphettades vid 10000 under 1,5 timmar. Överskottet av tionylklorid avdestillerades därefter, varvid man erhöll en olja som användes utan ytterligare rening. En lösning av oljan i dioxan sattes till en kall lösning av vattenhaltig dimetyl- amin (40 %; 56 ml) 1 dioxan, och den resulterande blandningen om- rördes vid 530 under l timme. Reaktionsblandningen hälldes därpå i utspädd saltsyra och extraherades med kloroform. Den organiska fasen torkades och indunstades, varvid man erhöll 56 g av en olja.Preparative Example 2. (a) 3- (N, N-dimethylaminomethyl) benzenemethanol. (1) 3- (N, N-dimethylaminocarbonyl) benzoic acid methyl fi å-- A mixture of 88 g of thionyl chloride and 33 g of benzene-1,3-decarboxylic acid monomethyl ester was heated at 10,000 for 1.5 hours. The excess thionyl chloride was then distilled off to give an oil which was used without further purification. A solution of the oil in dioxane was added to a cold solution of aqueous dimethylamine (40%; 56 ml) in dioxane, and the resulting mixture was stirred at 530 for 1 hour. The reaction mixture was then poured into dilute hydrochloric acid and extracted with chloroform. The organic phase was dried and evaporated to give 56 g of an oil.
Rf= 0,8 vid tunnskíktskromatografi på silikagel; etylacetat. NMR (CDCl3): 1,8 m (2H); 2,2-2,7 m (2H); 6,1 s (3H); 6,95 s (6H). (l)(b) Ovanstående exempel upprepades med användning av 70 g ester och 118 ml vattenhaltig metylamin (25 %). Härvid er- hölls 54 g 5-(N~mety1aminokarbonyl)bensoesyra-metylester med en smältpunkt av 128-13000. Rf= 0,57 vid tunnskiktskromatografi på silikagel; etylacetat. (2) 3-(N,N-dimetylaminometyl)bensenmetanol. 36 g 3-(N,N-dimetylaminokarbonyl)bensoesyra-metylester i torr tetrahydrofuran sattes till 16,6 g litiumalfiminiumhydrid i torr tetrahydrofuran. Reaktíonsblandningen värmdes vid 60°C un~ der 3 timmar, varefter den kyldes och behandlades med vatten.Rf = 0.8 by thin layer chromatography on silica gel; ethyl acetate. NMR (CDCl 3): 1.8 m (2H); 2.2-2.7 m (2H); 6.1 s (3 H); 6.95 s (6H). (l) (b) The above examples were repeated using 70 g of ester and 118 ml of aqueous methylamine (25%). This gave 54 g of 5- (N-methylaminocarbonyl) benzoic acid methyl ester with a melting point of 128-13000. Rf = 0.57 by thin layer chromatography on silica gel; ethyl acetate. (2) 3- (N, N-dimethylaminomethyl) benzenemethanol. 36 g of 3- (N, N-dimethylaminocarbonyl) benzoic acid methyl ester in dry tetrahydrofuran were added to 16.6 g of lithium aluminum hydride in dry tetrahydrofuran. The reaction mixture was heated at 60 ° C for 3 hours, after which it was cooled and treated with water.
Lösningsmedlet avlägsnades, och återstoden behandlades med utspädd saltsyra. Blandningen gjordes alkalisk med natriumhydroxid och extraherades med Kloroform. De organiska extrakten torkades och 1 destillerades, varvid man erhöll 16 g av en olja med en kokpunkt av 95-lOO°C vid 0,1 mm Hg. Rf= 0,57 vid tunnskiktskromatografi på silikagel; metanol. (2)(b) Ovanstående exempel upprepades med använd- ning av 25 g av estorn från (b) ovan. Härvid erhölls 9,2 g 3-(Nemetylaminometyl)bonsonmetanol med en kokpunkt av 110-ll5°C vid 0,02 mm Hg. Rf= 0,36 vid tunnskiktskromatografi på sílikagel; metanol.The solvent was removed, and the residue was treated with dilute hydrochloric acid. The mixture was made alkaline with sodium hydroxide and extracted with chloroform. The organic extracts were dried and distilled to give 16 g of an oil having a boiling point of 95 DEG-100 DEG C. at 0.1 mm Hg. Rf = 0.57 by thin layer chromatography on silica gel; methanol. (2) (b) The above examples were repeated using 25 g of the ester from (b) above. This gave 9.2 g of 3- (Nemethylaminomethyl) bonsone methanol with a boiling point of 110-115 ° C at 0.02 mm Hg. Rf = 0.36 by thin layer chromatography on silica gel; methanol.
Förberedande exemgel 1. (a) 2-/3-/§-(N,N-dimetylaminometyl)fenoxi7propyl7-lH-iS0- 7805591-Û 12- lndol-1¿2-§2H2-dion.Preparative Example 1. (a) 2- [3- [4- (N, N-dimethylaminomethyl) phenoxy] propyl] -1H-1SO- 7805591-12 12-indole-1 "2-§2H2-dione.
En blandning av 2,2 g 80 %-ig natriumhydrid och 6,95 g 5-(N,N-dimetylaminometyl)fenol i torr dimetylformamid omrördes vid 5°C under 2 timmar. Öärefter tillsattes 12,2 g N-(3-brompropyl)- ftalimid, och efter 16 timmar behandlades reaktionsblandningen med vatten och extraherades med etylacetat. Efter indunstning av de torkade organiska extrakten erhölls 15 g av den önskade föreningen såsom en gul olja. Rf= 0,35 vid tunnskiktskromatografi på silika- gel; etylacetat. Produktens oxalatsalt smälter vid 204-207°C.A mixture of 2.2 g of 80% sodium hydride and 6.95 g of 5- (N, N-dimethylaminomethyl) phenol in dry dimethylformamide was stirred at 5 ° C for 2 hours. Then 12.2 g of N- (3-bromopropyl) -phthalimide were added, and after 16 hours the reaction mixture was treated with water and extracted with ethyl acetate. After evaporation of the dried organic extracts, 15 g of the desired compound were obtained as a yellow oil. Rf = 0.35 by thin layer chromatography on silica gel; ethyl acetate. The oxalate salt of the product melts at 204-207 ° C.
De nedan angivna föreningarna framställdes på liknande sätt utgående från motsvarande fenol (Å) och lämplig bromalkyl- ftaiimid (B). (b) 14 g (A) plus 21,5 g (B) gav 21,4 g 2-¿3-¿3-(1-pyrro- lidinylmetyl)fenoxi7propyl7-lH-isoindol-1,5-(2H)-dion. nf=io,46 vid tunnskikbskromatografi på siiikagei; metanol:0,88O ammoniak (80:l). Föreningens oxalat- salt smälter vid 167-169°c.The following compounds were prepared in a similar manner starting from the corresponding phenol (Å) and the appropriate bromoalkylphthalimide (B). (b) 14 g (A) plus 21.5 g (B) gave 21.4 g of 2- [3- [3- (1-pyrrolidinylmethyl) phenoxy] propyl] -1H-isoindole-1,5- (2H) - dion. nf = io, 46 by thin layer chromatography on siiikagei; methanol: 0.88O ammonia (80: 1). The oxalate salt of the compound melts at 167-169 ° C.
(G) 5 e (Å) plus 9,3 s (B) gav 8,7 s 2~¿ï3¿3-(N,N-di- metylaminometyl)fenoxi7butyl7LlH-isoindol-1,3-(2H)- dion. Rf= 0,56 vid tunnskiktskromatografi på silika- gel; metanol:0,88 ammoniak (80:l). Föreningens oxa- iausaic smälter vid 169-17o°c. (d) 5 g (A) plus 8,1 g (B) gav 5 g 2-¿É-¿É-(N,N-dimetyl- - aminoetyl)fenox;7propyl7-lH-isoindol-l,5-(EH)-dion med en smäitpunku av 59-6o°c. nf= 0,45 vid tunnskikfis- kromatognafi på silikagel; etylacetatzisopropanolz vatten=o,88 ammoniak (25=15=8=2). (e) 2,0 g (A) pins 3,4 g (B) gav 2,8 g 2-¿F-¿3-(N,N-d1- metylaminoetyl)fenox¿7butyl7ßlH-isoindol-l,3-(2H)- Ådion med en smä1tpunkt.av¿52f53°C. RI=eO;55ßvid tunnskiktskromafiagrafi på sïi1kage1;'etv1acetan=¿. isopropanol:vatten:0,88 ammoniak (25íl5:8:2). _ (f) 2,2 e (Å) plus 5,2 s-(B) gav 2,5 a 2-¿3-¿5-(N»N~dï- metylaminopropyl)fenoxi7propyl7-1H-isoindol-1,}-(2H)- -diem med en xokpunkn av 25o°c vid o,1 mm Hg: Rf= 0,5 vid tunnskiktskromatografi på silikagel; etylacetat: isopropanolzvattenzammoniak (25:l5:8:2). (s) 2,2 s (Å) plus 5,4 s (B) gav 2,6 a 2-Äï1Ä3-(N-N-d1- metylaminopropyl)fenoxi7butyl7-lH-180inÖ0l-1,5-(25)- (h) (1) 7805591-Û 13 -dldn med en kdkpunkt av 225°c vid o,o4 mm Hg. Rr= 0,5 vid tunnskiktskromatografi på silikagel; etyl- acetatzisopropanol:vatten:0,88 ammoniak (25:l5:8:2). 7,0 g (A) plus 14,1 g (B) gav 3,8 g 2-¿E¶¿E-(N,N-d1- metylaminometyl)fenox¿7butyl7-lH-isoindol-1,3-(2H)- dion-oxalatsalt. Rf= 0,5 vid tunnskiktskromatografi på silikagel; metano1:0,88 ammoniak (80:l). 5 g (A) plus 9,7 g (B) gav 7,1 g 2-¿3-¿H-(N,N-dime- tylaminometyl)fenox;7propyl7-lH-isoindol-1,3-(2H)- -dion. Rf= 0,5 vid tunnskiktskromatografi på silika- gel; metanol:O,88 ammoniak (80:l). Föreningens oxa- lausalt smälter vid 166-l7o°c.(G) 5 e (Å) plus 9.3 s (B) gave 8.7 s of 2- [3- (N, N-dimethylaminomethyl) phenoxy] butyl] 11H-isoindole-1,3- (2H) -dione . Rf = 0.56 by thin layer chromatography on silica gel; methanol: 0.88 ammonia (80: 1). The oxa-ausaic of the compound melts at 169-170 ° C. (d) 5 g (A) plus 8.1 g (B) gave 5 g of 2-β-β- (N, N-dimethyl-aminoethyl) phenoxy; 7propyl7-1H-isoindole-1,5- EH) -dione with a melting point of 59-6o ° c. nf = 0.45 in thin layer fi s- chromatognaphy on silica gel; ethyl acetate isopropanolz water = 0.88 ammonia (25 = 15 = 8 = 2). (e) 2.0 g (A) Pins 3.4 g (B) gave 2.8 g of 2-β-β- (N, N-d1-methylaminoethyl) phenoxy] butyl7β1H-isoindole-1,3- (2H) - Ådion with a melting point of 522 ° C. RI = eO; 55ßvid thin-layer chromium fi agraphy on sïi1kage1; 'etv1acetan = ¿. isopropanol: water: 0.88 ammonia (25 [mu] l5: 8: 2). (f) 2.2 e (Å) plus 5.2 s- (B) gave 2.5 to 2-β-β- (N »N-dimethylaminopropyl) phenoxy] propyl7-1H-isoindole-1, } - (2H) -diem with an xo point of 25 ° C at 0.1 mm Hg: Rf = 0.5 by thin layer chromatography on silica gel; ethyl acetate: isopropanol-aqueous ammonia (25: 15: 8: 2). (s) 2.2 s (Å) plus 5.4 s (B) gave 2.6 α 2-β1- [3- (NN-d1-methylaminopropyl) phenoxy] butyl] -1H-180inO1-1,5- (25) - (h) ) (1) 7805591-Û 13 -dldn with a boiling point of 225 ° C at 0.4 mm Hg. Rr = 0.5 by thin layer chromatography on silica gel; ethyl acetate isopropanol: water: 0.88 ammonia (25: 15: 8: 2). 7.0 g (A) plus 14.1 g (B) gave 3.8 g of 2-β- (N, N-d1-methylaminomethyl) phenoxy] butyl7 -1H-isoindole-1,3- ( 2H) - dione oxalate salt. Rf = 0.5 by thin layer chromatography on silica gel; methano1: 0.88 ammonia (80: 1). 5 g (A) plus 9.7 g (B) gave 7.1 g of 2-β-βH- (N, N-dimethylaminomethyl) phenox; 7propyl7-1H-isoindole-1,3- (2H) - -dion. Rf = 0.5 by thin layer chromatography on silica gel; methanol: 0.88 ammonia (80: 1). The oxalausal compound of the compound melts at 166-170 ° C.
Förberedande exemgel 4. (a) 2-/5-/ï-(N,N-dlmstvlamlnsmstyl)fenox17è:vl7-lH-1s0- indol-1,2-(EH)-dion. 5,0 g 3-(N,N-dimetylaminometyl)fenol, 1,2 g 80 %-lg nat- riumhydrid och 15 g 2-¿§-(Ä-metylbensensulfonyl)etyl7-lH-isoindol- -1,3-(en)-dldn uppnetuades vid 9o°c 1 dlmetylfdrmamld. Efter 12 timmar kyldes reaktionsblandningen, hälldes i isvatten och extra- herades med eter. Efter avdunstning av det organiska lösningsmed- let erhölls 5,2 g produkt 1 form av en viskös, gul olja. Rf= 0,37 vid tunnskiktskromatografi på silikagel; metanolzetylacetat (lzl).Preparative Example 4. (a) 2- [5- [1- (N, N-dimethylaminyl) phenox17]: 177-1H-150-indole-1,2- (EH) -dione. 5.0 g of 3- (N, N-dimethylaminomethyl) phenol, 1.2 g of 80% sodium hydride and 15 g of 2-β- (α-methylbenzenesulfonyl) ethyl 7-1H-isoindole-1,3- (en) -dldn was precipitated at 90 ° C in dimethylformamide. After 12 hours, the reaction mixture was cooled, poured into ice water and extracted with ether. After evaporation of the organic solvent, 5.2 g of product were obtained in the form of a viscous yellow oil. Rf = 0.37 by thin layer chromatography on silica gel; methanol zetylacetate (lzl).
Produktens dxslsusslt smälter vid 166-l67°c.The product's melt melts at 166 DEG-167 DEG C.
De nedan angivna föreningarna framställdes på liknande sätt utgående från motsvarande fenol (A) och 2-[§-(4-mety1bensen- sulrsnyl)efiy;7-ln-lsolnddl-l,3-(an)-dldn (c). (b) (0) 5 g (A) plus 11,7 G (c) gav 2,u g 2<[š,¿š-(N,N-d1- metylsminoeuyl)fsnsx¿7efiyl7_lH-lssinddl-l,3-(an)_ -dlsn med en smältpunkt av 84-85°c. Rf= 0,45 vid tunnskiktskromatografi på silikagel; etylacetat: isopropano1:vatten:0,88 ammoniak (25:l5:8:2). 2,2 g (Å) plus Ä,2 g (C) gav 0,5 g 2-¿§-¿É-(N,N-di- metylaminopropyl)fenoxi7etyl7-lH-isoindol-1,}-(2H)- -dion. Rf= 0,45 vid tunnskiktskromatografi på silika- gel; etylacetat:isopropanol:vatten:0,88 ammoniak (25:l5:8:2).The compounds listed below were prepared in a similar manner starting from the corresponding phenol (A) and 2- [§- (4-methylbenzenesulfonyl) e] y; 7-ln-1solnddl-1,3- (an) -dldn (c). (b) (0) 5 g (A) plus 11.7 G (c) gave 2, ug 2 <[š, ¿š- (N, N-d1-methylsminoeuyl) fsnsx¿7e fi yl7_1H-lssinddl-1,3- (an) _ -dlsn with a melting point of 84-85 ° c. Rf = 0.45 by thin layer chromatography on silica gel; ethyl acetate: isopropanol: water: 0.88 ammonia (25: 15: 8: 2). 2.2 g ()) plus,, 2 g (C) gave 0.5 g of 2-β-β- (N, N-dimethylaminopropyl) phenoxyethyl] -1H-isoindole-1,1- (2H) - -dion. Rf = 0.45 by thin layer chromatography on silica gel; ethyl acetate: isopropanol: water: 0.88 ammonia (25: 15: 8: 2).
Förberedande exempel Q. (a) 2-/É-/É-(N,N-dimetylaminometyl)fenoxi7propyL7lH-iso- indol-l - 2H -digg, - r Q 7805591-Û 14 (1) 2-/3-/3-(formyl)fenoxi7bropyl7-1H-isoindol-l,3- -(2H2-dion. 0,61 g 3-hydroxibensaldehyd, 1,31 g 3-brompropylftalimid och kaliumkarbonat omrördes 1 dimetylformamid vid rumstemperatur under 16 timmar. Reaküonsüandningenfhälldes därefter 1 vatten för utfällning av titelföreningen. Efter avfiltrering och torkning erhölls 1,37 g produkt med en smältpunkt av 102-10ä°C. Rf= 0,65 vid tunnskiktskromatografi på silikagel; metanolztoluen (l:9).Preparative Example Q. (a) 2- [E- / E- (N, N-dimethylaminomethyl) phenoxy] propyl] 71H-isoindole-1,2H-digg, - r Q 7805591-Û 14 (1) 2- / 3- / 3- (Formyl) phenoxy7bropyl7-1H-isoindole-1,3- (2H2-dione. 0.61 g of 3-hydroxybenzaldehyde, 1.31 g of 3-bromopropylphthalimide and potassium carbonate were stirred in dimethylformamide at room temperature for 16 hours. After precipitation and drying, 1.37 g of product with a melting point of 102 DEG-10 DEG C. were obtained, Rf = 0.65 by thin layer chromatography on silica gel, methanol (toluene) (1: 9).
De nedan angivna föreningarna framställdes på liknande sätt. . (l)(b) 5 g 4-hydroxibensaldehyd och 10,4 g lämplig ftalimid gav 1,3 g 2¿¿§¿¿ï-(formyl)fenoxi7etyl7¥1H-isoindol-1,3- -(2H)-dion med en smältpunkt av 131,5-135,5°c. Rf= 0,5 vid tunn- skiktskromatografi på silikagel; metanolzkloroform (l:lOO). (l)(c) 6,1 g 2-hydroxibensaldehyd och 12 g lämplig ftalimid gav 12,2 g 2@¿H-¿ë-(formvi)fenøx;7buuy;7-1H-isoinaol-1,5- -(2H)-dion med en smaltpunkt av 99,5-1o1°c. Rf= 0,8 vid tunnskikts- kromatografi på silikagel; metanol:O,88 ammoniak (80:l). (2) 2-/3-/3-(N,N-dimetylaminometyi)fenox17pr0py;7- -lH-isoindol-1,3-(QH)-dion. 132 g 2-¿3-¿3-(formyl)ren°x;7pr@pv;7-1H-isoinaoi-1,3-(en)- -dion och 300 ml 33 %-ig etanolisk dimetylamin hydrerades vid rums- temperatur och atmosfärstryck 1 etanol över 10 % palladium pà trä- kol. Katalysatorn avfiltrerades därefter, och filtratet indunsta- des, varvid man erhöll 142 g av den önskade föreningen såsom en gul olja. Rf = 0,35 vid tunnskiktskromatografi på silikagel; etyl- acetat. Föreningens oxalatsalt smälter vid 204-20700, De nedan angivna föreningarna framställdes på liknande sätt utgaenae_r;àn 53 %-ig etanolisk aimetylamin och motsvarande ftaiimid (B);“"' - (2)(b) 1,2 g P plus 20 ml 33 %-ig etanolisk dime- tylamin gav 1,3 g 2-[§-[F-(N,N-dimetylaminometyl)fenoxi7etyl7-lH- -isoindol-1,3-(2H)-dion. Rf= 0,3 vid tunnskiktskromatografi på silikagel; metanol:0,88 ammoniak (80:l). (2)(c) 10 g P plus 50 ml 33 %-ig etanolisk dimetyl- amin gav 7 g 2-¿ï-¿É-(N,N-dimetylaminometyl)fenoxi7butyl7-lH-1so- indol-1,3-(2H)-dion. Rf= 0,55 vid tunnskiktskromatografi på silika- gel; metanol:0,88 amoniak (80:l). Produktens oxalatsalt smälter vid 162-163°c. 7805591-Û Förberedande exempel 6. 2-/É¿/7É-(N,N-dimetvlaminometyl)- fenyl7tio7bropyl7-lH-isoindol-ll3 -§2H2-dion. (1) Ditio-bis;3,3'-N,N-dimetylbensenkarboxamid. . 57 m1 aimetylamin 1 toiuen sattes vid 5°c till 46 g 3,5'-ditio-(klorkarbonyl)bensen i toluen. Efter 4 timmar tillsattes vatten, och lösningen extraherades med etylacetat. Efter indunst- ning av extrakten erhölls 49 g av den önskade föreningen såsom en orangefärgad olja. NMR (CDCl5): 2,4-2,8 m (8H); 7,05 br (l2H). (2) Ditio-bis-3,3'-N,N-dimetylbensenmetanamin. 48 g 3,3'-ditio-N,N-dimetylbensenkarboxamid i torr eter sattes till 20 g litiumaluminiumhydrid 1 torr eter. Reaktionsbland- ningen omrördes vid rumstemperatur, varefter den kyldes, behandla- des med vatten och filtrerades. Filtratet extraherades med etyl- acetat, och extraktet torkades och destillerades. Härvid erhölls 8,8 g av en färglös olja med en koxpunkt av 25o°c vid o,1 mm Hg.The compounds listed below were prepared in a similar manner. . (l) (b) 5 g of 4-hydroxybenzaldehyde and 10.4 g of the appropriate phthalimide gave 1.3 g of 2β-(formyl) phenoxyethyl] -1H-isoindole-1,3- (2H) -dione with a melting point of 131.5-135.5 ° C. Rf = 0.5 by thin layer chromatography on silica gel; methanol / chloroform (100: 100). (1) (c) 6.1 g of 2-hydroxybenzaldehyde and 12 g of the appropriate phthalimide gave 12.2 g of 2 [3 H] -β (phenyl) phenoxyl; 7-butyl; 2H) -dione with a melting point of 99.5-110 ° C. Rf = 0.8 by thin layer chromatography on silica gel; methanol: 0.88 ammonia (80: 1). (2) 2- [3- [3- (N, N-dimethylaminomethyl) phenoxy] propyl; 7-1] isoindole-1,3- (QH) -dione. 132 g of 2-β-β- (formyl) pure α, β-β-β, β-1H-isoamino-1,3- (one) -dione and 300 ml of 33% ethanolic dimethylamine were hydrogenated temperature and atmospheric pressure 1 ethanol over 10% palladium on charcoal. The catalyst was then filtered off and the filtrate was evaporated to give 142 g of the desired compound as a yellow oil. Rf = 0.35 by thin layer chromatography on silica gel; ethyl acetate. The oxalate salt of the compound melts at 204-20700. The following compounds were prepared in a similar manner starting from 53% ethanolic acetylamine and the corresponding phthalimide (B); (") (2) (b) 1.2 g P plus 20 ml 33% ethanolic dimethylamine gave 1.3 g of 2- [§- [F- (N, N-dimethylaminomethyl) phenoxy] ethyl] -1H- -isoindole-1,3- (2H) -dione Rf = 0.3 by thin layer chromatography on silica gel, methanol: 0.88 ammonia (80: 1) (2) (c) 10 g P plus 50 ml 33% ethanolic dimethylamine gave 7 g 2-¿ï-¿É- (N , N-dimethylaminomethyl) phenoxy7butyl7 -1H-1so-indole-1,3- (2H) -dione Rf = 0.55 by thin layer chromatography on silica gel; methanol: 0.88 ammonia (80: 1) The product oxalate salt melts at 162 DEG-163 DEG C. 7805591-Û Preparative Example 6. 2- [R 3,3'-N, N-dimethylbenzenecarboxamide 57 ml of acetylamine in toluene was added at 5 ° C to 46 g of 3,5'-dithio- (chlorocarbonyl) benzene in toluene. tat. After evaporation of the extracts, 49 g of the desired compound were obtained as an orange oil. NMR (CDCl 5): 2.4-2.8 m (8H); 7.05 br (12H). (2) Ditio-bis-3,3'-N, N-dimethylbenzenemethanamine. 48 g of 3,3'-dithio-N, N-dimethylbenzenecarboxamide in dry ether were added to 20 g of lithium aluminum hydride in dry ether. The reaction mixture was stirred at room temperature, then cooled, treated with water and filtered. The filtrate was extracted with ethyl acetate, and the extract was dried and distilled. This gave 8.8 g of a colorless oil having a boiling point of 25 DEG C. at 0.1 mm Hg.
NMR (cncl )= 2,5-2,9 m (8H); 6,66 s (4H); 7,8 s (6H). (5) 2-/3-[75-(N,N-aimetylaminømetyi)feny17t167pr6py17- -lH-isoindol-l,j(2H)-dion. 2,3 g 80 %-ig natriumhydrid och 7,8 g ditio-bis-},}'-N,N- -dimetylbensenmetanamin omrördes vid rumstemperatur i torr dimetyl- formamid under 24 timmar. Därefter tillsattes 12,6 g N-(3-brompro~ pyl)fta1imid. Efter 2ü timmar behandlades reaktionsblandningen med vatten och extraherades med etylacetat. De organiska extrakten indunstades, och återstoden renades genom kolonnkromatografi på kiseldioxid, varvid man eluerade med en blandning av etylacetat och metanol. Man erhöll härvid ll,3 g av den önskade föreningen såsom en ljust orangefärgad olja. NMR (CDCl3): 2,0-2,4 m (4H); 2:6"'2:9 m 6:15 t (Qlnf s (21%): 7,02 t (QIÜÉ 5 (6H); 7,98 m (EH)- Exempel A. 3-(3-aminopropoxi)-N-metylbensenmetanamin- -dioxalat. (1) 3-/É-(formyl)fenoxi7progignitril.NMR (cncl) = 2.5-2.9 m (8H); 6.66 s (4 H); 7.8 s (6 H). (5) 2- [3- [75- (N, N-methylaminomethyl) phenyl] -167propyl] -1H-isoindole-1,1 (2H) -dione. 2.3 g of 80% sodium hydride and 7.8 g of dithio-bis-N, N-dimethylbenzenemethanamine were stirred at room temperature in dry dimethylformamide for 24 hours. Then 12.6 g of N- (3-bromopropyl) phthalimide were added. After 2 hours, the reaction mixture was treated with water and extracted with ethyl acetate. The organic extracts were evaporated, and the residue was purified by column chromatography on silica, eluting with a mixture of ethyl acetate and methanol. This gave 11.3 g of the desired compound as a light orange oil. NMR (CDCl 3): 2.0-2.4 m (4H); 2: 6 "'2: 9 m 6:15 t (Qlnf s (21%): 7.02 t (QIÜÉ 5 (6H); 7.98 m (EH) - Example A. 3- (3-aminopropoxy) -N-methylbenzenemethanamine dioxalate (1) 3- [E- (formyl) phenoxy] progignitrile.
En lösning av 50,5 g m-hydroxibcnsaldehyd i 265 ml akryl- nitril och 5 ml 40 %-ig metanolisk bensyltrimetylammonïumhydroxid kokades under àterflöde i 20 timmar. Reaktionsblandningen utspäddes därefter med 500 ml eter, och den resulterande lösningen tvättades med en 5 %-ig natriumhydroxidlösning och därefter med vatten. Eter- lösningen torkades över magnesiumsulfat, filtrerades och indunsta- 7805591-Û _ /6 .des 1 vakuum. Härvid erhölls 32 g av en klar, färglös olja. Rf= 0,4 vid tunnskiktskromatografi på silikagel; kloroform. (2) 3-(2-cyanetoxfl-N-metylbensenmetanamin-hydroklorid.A solution of 50.5 g of m-hydroxybenzaldehyde in 265 ml of acrylonitrile and 5 ml of 40% methanolic benzyltrimethylammonium hydroxide was refluxed for 20 hours. The reaction mixture was then diluted with 500 ml of ether, and the resulting solution was washed with a 5% sodium hydroxide solution and then with water. The ether solution was dried over magnesium sulfate, filtered and evaporated in vacuo. 32 g of a clear, colorless oil were obtained. Rf = 0.4 by thin layer chromatography on silica gel; chloroform. (2) 3- (2-Cyanethoxy fl-N-methylbenzenemethanamine hydrochloride.
En lösning av 8,75 g 3-¿3¥(formy1)fenoxlfpropionitril i en blandning av 50 ml 55 %-ig etanolisk metylamin och 200 ml etanol omrördes vid rumstemperatur med 0,8 g 5 % palladium på träkol under en vätgasatmosfär med trycket 1 atmosfär. Efter det att upptagningen av väte hade upphört, filtrerades blandningen och återstoden tvättades med etanol. Det etanoliska filtratet och tvättlösningarna förenades, varefter den resulterande bland- ningens volym minskades och koncentratet behandlades med ett över- skott av en eterlösning av väteklorid. Den utfällda hydrokloriden omkristalliserades 1 en blandning av etanol och eter, varvid man erhöll 7,9 g av den önskade föreningen 1 form av färglösa plattor med en smältpunkt av 125-12800.A solution of 8.75 g of 3- [3 (phenyl) phenoxylpropionitrile in a mixture of 50 ml of 55% ethanolic methylamine and 200 ml of ethanol was stirred at room temperature with 0.8 g of 5% palladium on charcoal under a hydrogen atmosphere with pressure 1 atmosphere. After the uptake of hydrogen ceased, the mixture was filtered and the residue was washed with ethanol. The ethanolic filtrate and the washing solutions were combined, after which the volume of the resulting mixture was reduced and the concentrate was treated with an excess of an ethereal solution of hydrogen chloride. The precipitated hydrochloride was recrystallized from a mixture of ethanol and ether to give 7.9 g of the desired compound as colorless plates, m.p. 125-12800.
Analys: Beräknat för cl1Hl5c1N2o: c 58,3 H 6,5 N 12,35 % Funnet: C 58,1 H 6,5 N 12,5 % (3) 5-(3-aminopropoxi)-N-metylbensenmetanamín-dioxalat.Analysis: Calculated for C 11 H 15 ClN 2 O: c 58.3 H 6.5 N 12.35% Found: C 58.1 H 6.5 N 12.5% (3) 5- (3-aminopropoxy) -N-methylbenzenemethanamine dioxalate .
En lösning av 5,39 g N-metyl-[Éë(2-cyanetoxi)bensenmetan- amin-hydroklorid i 50 ml metanol eluerades genom en anjonbytar-n kolonn (Amberlyst A-26), och eluatet indunstades, varvid den fria basen erhölls såsom en färglös olja. Den fria basen löstes 1 500 ml etanol och 25 ml 0,88 ammoniaklösning, och den resulteran-_ de lösningen skakades med-2,5 g 5 % rodium på aluminiumoxid vid rumstemperatur under 6 timmar under ett vätgastryck av 280 kPa.A solution of 5.39 g of N-methyl- [ε (2-cyanethoxy) benzenemethanamine hydrochloride in 50 ml of methanol was eluted through an anion exchange column (Amberlyst A-26), and the eluate was evaporated to give the free base. such as a colorless oil. The free base was dissolved in 1,500 ml of ethanol and 25 ml of 0.88 ammonia solution, and the resulting solution was shaken with 2.5 g of 5% rhodium on alumina at room temperature for 6 hours under a hydrogen pressure of 280 kPa.
Den resulterande suspensionen filtrerades, och filtratet indunsta- des 1 vakuum. Den erhållna återstoden löstes i etanol och behand- lades med ett överskott av etanolisk oxalsyra. Det utfällda die- oxalatsaltet avfiltrerades och torkades, Man erH5ll{6,§6-g.dioxa- latsalt med en smältpunkt av 196-l98°C. Rf= 0,1 vid tunnskiktskro- matografi på silikagel; metano1:O,88 ammoniak (99:l).The resulting suspension was filtered, and the filtrate was evaporated in vacuo. The resulting residue was dissolved in ethanol and treated with an excess of ethanolic oxalic acid. The precipitated dioxalate salt was filtered off and dried, yielding 6.6 g of dioxalate salt, m.p. 196-198 ° C. Rf = 0.1 in thin layer chromatography on silica gel; methano1: 0.88 ammonia (99: 1).
Exempel B. 3-(3-aminopropo;ilfN-metylbensenmetanam1n- -dioxalat. 8,5 g 2-¿3-¿3:(formy1)fen0x;7propy;7-in-isoindoi-1,3-(an)- -dion omrördes under l timme 1 300 ml av en 53 %-ig etanollösning av metylamin och hydrerades därefter vid rumstemperatur och atmos färstryck 1 etanol över 10 % palladium på träkol. Reaktionsbland- ningen filtrerades därefter, och filtratet indunstades till torr- 7805591-0 17 het i vakuum. Återstoden löstes i 50 ml etanol, och den erhållna etanollösningen behandlades med ett överskott av etanolisk oxal- syra. Den bildade fällningen omkristalliserades i en blandning av etanol och vatten. Man erhöll härvid 5,9 g av den önskade före- ningen i form av färglösa korn med en smältpunkt av 196-19800.Example B. 3- (3-Aminopropoyl) -N-methylbenzenemethanamine-dioxalate 8.5 g of 2-β-β: (formyl) phenoxy; 7propyl; 7-in-isoindol-1,3- (an) - The dione was stirred for 1 hour in 300 ml of a 53% ethanol solution of methylamine and then hydrogenated at room temperature and atmospheric pressure in ethanol over 10% palladium on charcoal. The reaction mixture was then filtered, and the filtrate was evaporated to dryness. The residue was dissolved in 50 ml of ethanol, and the resulting ethanol solution was treated with an excess of ethanolic oxalic acid, the precipitate formed was recrystallized from a mixture of ethanol and water to give 5.9 g of the desired compound. in the form of colorless grains with a melting point of 196-19800.
Rf= 0,1 vid tunnskiktskromatografi på silikagel; metanol:O,88 ammoniak (20:l)¿ Exemgel C. (a) 3-(5-aminopropoxi)-N,N-dimetylbensenmetanamin. 25 g 2-¿É-[É-(N,N-dimetylaminometyl)fenox;7propyl7-lH- -isoindol-1,3-(QH)-dion behandlades med 150 ml av en 50 %-ig etanollösning av metylamin. Efter 24 timmar vid rumstemperatur tillsattes 100 ml eter, och ett fast ämne avfiltrerades. Filtrat- et destillerades, varvid man erhöll 12,3 g av den önskade före- ningen såsom en gul olja med en kokpunkt av 102-1l2°C vid 0,2 mm Hg. Rf= 0,25 vid tunnskiktskromatografi på silikagel; etylacetat: isopropanol:vatten:0,88 ammoniak.Rf = 0.1 by thin layer chromatography on silica gel; methanol: 0.88 ammonia (20: 1) Example 2 C. (a) 3- (5-aminopropoxy) -N, N-dimethylbenzenemethanamine. 25 g of 2- [2- (N, N-dimethylaminomethyl) phenoxyl] propyl] -1H-isoindole-1,3- (QH) -dione were treated with 150 ml of a 50% ethanol solution of methylamine. After 24 hours at room temperature, 100 ml of ether were added, and a solid was filtered off. The filtrate was distilled to give 12.3 g of the desired compound as a yellow oil having a boiling point of 102-112 ° C at 0.2 mm Hg. Rf = 0.25 by thin layer chromatography on silica gel; ethyl acetate: isopropanol: water: 0.88 ammonia.
De nedan angivna föreningarna framställdes på liknande sätt utgående från motsvarande ftalimid (C). (b) 5,4 g (C) gav 0,45 g 3-(2-aminoetoxi)-N,N-dimetyl- bensenmetanamin. Rf= 0,04 vid tunnskiktskromatogra- fi pa siiikagel; m@uan01=ammon1ax (8o=1). NMR (cnci ) 2,8-5,1 m (ÄH); 6,05 t (2H); 6,55 S (2H); 6,98 t (arm 7,80 s (en), 8,4 bas (an). ' (e) 2,9 g (c) gav 0,8 g Iz-(ls-aminobuuoxi)-Nm-dimetyl- bensenmetanamin-bisoxalatsalt. Rf= 0,17 vid tunn- skiktskromatografi på silikagel; metanol:O,88 ammo- niak. NMR (1320): 2,5-2,9 m (lm), 5,7 s (2H),- 5,8 m (2H); 6,85 m (an),- 7,12 s (6H); 8,09 m (lm). (d) 6,6 g (C) gav 1,2 g 4-(3-aminopropoxi)-N,N-dimetyl- bensenmetânamin-bisoxalatsalt. NMR (D20): 2,5-2,87 m (4H); 5.72 s <2H>; 5,75 h (2H); 6,7 c (2H); 7,13 S (6H); 7,78 m (2H)-' r Exemgel D. (a) 3-(3-aminopropoxi)-N,N-dimetylbensenmetanamin. 90 g 2-1?-Ä?-(N,N-dimetylaminometyl)fenoxi7propyl7-lH- -isoindol-1,3-(EH)-dion och 200 ml av en 30 %-ig vattenlösning av metylamin upphettades vid 80°C. Efter 4 timmar kyldes reaktions- 18 7805591-Û blandningen, alkaliserades med 5 N natriumhydroxidlösning och extraherades med toluen. Toluenextraktet destillerades, varvid ' man erhöll 43,1 g'av den önskade föreningen såsom en ljusgul olja med en kexpunku ev 102-112°c vid 0,2 mm Hg. nr= 0,25 vid uunnexixne kromatografi på silikagel; etylacetat:isopropanol:vatten:O,88 ammo- niak (25:15:8:2).The following compounds were prepared in a similar manner starting from the corresponding phthalimide (C). (b) 5.4 g (C) gave 0.45 g of 3- (2-aminoethoxy) -N, N-dimethylbenzenemethanamine. Rf = 0.04 in thin layer chromatography on silica gel; m @ uan01 = ammon1ax (8o = 1). NMR (cnci) 2.8-5.1 m (1H); 6.05 t (2H); 6.55 S (2H); 6.98 t (arm 7.80 s (en), 8.4 base (an). '(E) 2.9 g (c) gave 0.8 g of Iz- (1s-aminobuuoxy) -Nm-dimethyl- benzene methanamine bisoxalate salt Rf = 0.17 by thin layer chromatography on silica gel, methanol: 0.88 ammonia NMR (1320): 2.5-2.9 m (lm), 5.7 s (2H), - 5.8 m (2H), 6.85 m (an), - 7.12 s (6H), 8.09 m (1m). (D) 6.6 g (C) gave 1.2 g 4 - (3-aminopropoxy) -N, N-dimethylbenzenemethanamine bisoxalate salt NMR (D 2 O): 2.5-2.87 m (4H); 5.72 s <2H>; 5.75 h (2H); 6, 7 c (2H); 7.13 S (6H); 7.78 m (2H) - 'Exemgel D. (a) 3- (3-aminopropoxy) -N, N-dimethylbenzenemethanamine 90 g 2-1? N - (N, N-dimethylaminomethyl) phenoxy] propyl 7 -1H- -isoindole-1,3- (EH) -dione and 200 ml of a 30% aqueous solution of methylamine were heated at 80 ° C. After 4 hours the reaction was cooled. The mixture was alkalized with 5 N sodium hydroxide solution and extracted with toluene, the toluene extract being distilled to give 43.1 g of the desired compound as a light yellow oil with a biscuit puncture at 102-112 ° C at 0.2 ° C. mm Hg. nr = 0.25 at uunnexixn chromatography on silica gel; ethyl acetate: isopropanol: water: 0.88 ammonia (25: 15: 8: 2).
De nedan angivna föreningarna framställdes på liknande sätt utgående från motsvarande ftalimid (C). (b) 6,7 g (C) gav 1,2 g 3-(4-aminobutoxi)-N,N-dimetyl- bensenmetanamin. Rf= 0,24 vid tunnskiktskromatogra- fi på silikagel; metanol:O,88 ammoniak (80:l). (c) 2,6 g (c) gav 1,3 g 5-¿3-(1-pyrrelidinylmecyi)renox¿7 propylamin i form av bisoxalatsalt med en smältpunkt av 184-185°c. Rf= 0,3 vid cunnskiktskremecegrafi på silikagel; metanol:O,88 ammoniak (l9:1).The following compounds were prepared in a similar manner starting from the corresponding phthalimide (C). (b) 6.7 g (C) gave 1.2 g of 3- (4-aminobutoxy) -N, N-dimethylbenzenemethanamine. Rf = 0.24 by thin layer chromatography on silica gel; methanol: 0.88 ammonia (80: 1). (c) 2.6 g (c) gave 1.3 g of 5- [3- (1-pyrrelidinylmecyl) renoxyl] propylamine in the form of bisoxalate salt with a melting point of 184-185 ° C. Rf = 0.3 in cunn layer gel cegraphy on silica gel; methanol: 0.88 ammonia (19: 1).
Exemgel E) (a) 3-(5-aminopropoxi)-N,N-dimetylbensenmetanamin. 12,2 g 2-¿§-¿É-(N,N-dimetylaminometyl)fenoxi7propyl7-lH- -isoindol-1,3-(2H)-dion och 2,1 ml hydrazinhydrat kokades under âterflöde i etanol under 3 timmar. Reaktionsblandningen kyldes därefter och filtrerades, och filtratet destillerades. Härvid er- hölls 2 g av den önskade föreningen såsom en färglös olja med en xekpunk: ev 127°c vid 0,6 mm Hg. Föreningens hydrekleriasalc smäl- te vid 212-215°c. - - In nedan angivna föreningarna framställdes på liknande sätt utgående från motsvarande ftalimid (C). (b) 2,8 g (C) gav 1,7 g 3-(2-aminoetoxi)-N,N-dimetyl- beneeneeenemin med en kekpunkt av 135°c vid o§o3 'mm Hg. Rf= 0,5 vid uunnskiktexremenegrefi på siiike- gel; etylacetat:isopropano1:vatten:O,88 ammoniak (25:l5:8:2). Ü Vi __ 7 7 (c) 4,2 g (C) gav 2 g 3-(3-aminopropoxi)-N,N-dimetylben- senetanamín med en kokpunkt av 95°C vid 0,03 mm Hg.Example gel E) (a) 3- (5-aminopropoxy) -N, N-dimethylbenzenemethanamine. 12.2 g of 2-β-β- (N, N-dimethylaminomethyl) phenoxypropyl] -1H-isoindole-1,3- (2H) -dione and 2.1 ml of hydrazine hydrate were refluxed in ethanol for 3 hours. The reaction mixture was then cooled and filtered, and the filtrate was distilled. This gave 2 g of the desired compound as a colorless oil with a hex point: possibly 127 ° C at 0.6 mm Hg. The hydrochloric acid of the compound melted at 212-215 ° C. The compounds listed below were prepared in a similar manner starting from the corresponding phthalimide (C). (b) 2.8 g (C) gave 1.7 g of 3- (2-aminoethoxy) -N, N-dimethylbeneneeneemine with a boiling point of 135 ° C at 0 ° 3 'mm Hg. Rf = 0.5 in case of uneven layer exremegrefi on siiikegel; ethyl acetate: isopropanol: water: 0.88 ammonia (25: 15: 8: 2). (C) 4.2 g (C) gave 2 g of 3- (3-aminopropoxy) -N, N-dimethylbenzenetanamine having a boiling point of 95 ° C at 0.03 mm Hg.
Rf= 0,3 vid tunnskiktskromatografi på silikagel; etylacetat:isopropanol:vatten:0,88 ammoniak (25:l5: 8:2). (d) 2,5 g (C)'gav 0,9 g 5-(4-aminobutoxi)-N,N-dimetyl- bensenetanamin med en kokpunkt av 150°C vid 0,04 mm Hg. Rf= 0,3 vid tunnskiktskromatoåfllfi På sïlïkaåelï (e) (f) (e) (h) (1) (J) 7805591-0 19 etylacetat:isopropanol:vatten:0,88 ammoniak (25:15: 8:2). 0,5 g (C) gav 0,26 g 3-(2-aminoetoxi)-N,N-dimety1- bensenpropanamin med en kokpunkt av 13000 vid 0,03 mm Hg. Rf= 0,45 vid tunnskiktskromatografi på sili-I kagel; etylacetatzvatten:isopropanol:O,88 ammoniak (25:8:15:2). 2 g (C) gav 0,95 g 3_(3-am1n0propoxi)-N,N-dimeby1- bensenpropanamin med en kokpunkt av l60°C vid 0,04 mm Hg. Rr= 0,3 vid uunnskiktskromatografi på si11¿ kagel; etylacetat:vatten:isopropanol:0,88 ammoniak (25=8=15=2). 2 g (C) gav 1,05 g 3-(4-aminobutoxi)-N,N-dimetyl- bensenpropanamin med en kokpunkt av 130°C vid 0,04 mm Hg. Rf= 0,25 vid tunnskiktskromatografi på sili- kagel; etylacetatzvattenzisopropanol:0,88 ammoniak (25:8:15:2). 1l,5_g (C) gav 2,3 g 3-[X5-aminopropyl)tig7-N,N-di- metylbensenmetanamin med en kokpunkt av 14200 vid 0,1 mm Hg. NMR (CDCl3): 2,5-3 m (4H); 6,6 s (2H); 6.99 t (3H); 7,17 t (2H); 7,76 S (6H); 8,22 m (2H); 8,58 bre (2H). 1,3 g (C) gav 0,28 g 4-12-aminoetoxi7-N,N-dimetyl- bensenmetanamin med en kokpunkt av 90°C vid 0,04 mm Hg. Rf= 0,2 vid tunnskiktskromatografi på sili- kagel; metano1:0,88 ammoniak (80:l). 7 g (C) gav 2,7 g 2-(4-aminobutoxi)-N,N-dimetylben- senmetanamin med en kokpunkt av 90°C vid 0,07 mm Hg. Rf= 0,2 vid tunnskiktskromatografi på silika- gel; metanol:0,88 ammoniak (80:1).Rf = 0.3 by thin layer chromatography on silica gel; ethyl acetate: isopropanol: water: 0.88 ammonia (25: 15: 8: 2). (d) 2.5 g (C) 'gave 0.9 g of 5- (4-aminobutoxy) -N, N-dimethylbenzenethanamine having a boiling point of 150 ° C at 0.04 mm Hg. Rf = 0.3 at thin layer chromato fi lfi On silica (e) (f) (e) (h) (1) (J) 7805591-0 19 ethyl acetate: isopropanol: water: 0.88 ammonia (25:15: 8: 2) . 0.5 g (C) gave 0.26 g of 3- (2-aminoethoxy) -N, N-dimethylbenzenepropanamine having a boiling point of 13000 at 0.03 mm Hg. Rf = 0.45 by thin layer chromatography on silica gel; ethyl acetate water: isopropanol: 0.88 ammonia (25: 8: 15: 2). 2 g (C) gave 0.95 g of 3- (3-aminopropoxy) -N, N-dimethylbenzenepropanamine with a boiling point of 160 ° C at 0.04 mm Hg. Rr = 0.3 by layer chromatography on si11¿ cone; ethyl acetate: water: isopropanol: 0.88 ammonia (25 = 8 = 15 = 2). 2 g (C) gave 1.05 g of 3- (4-aminobutoxy) -N, N-dimethylbenzenepropanamine with a boiling point of 130 ° C at 0.04 mm Hg. Rf = 0.25 by thin layer chromatography on silica gel; ethyl acetate water zisopropanol: 0.88 ammonia (25: 8: 15: 2). 1.5 g (C) gave 2.3 g of 3- [X5-aminopropyl) tig7-N, N-dimethylbenzenemethanamine with a boiling point of 14200 at 0.1 mm Hg. NMR (CDCl 3): 2.5-3 m (4H); 6.6 s (2 H); 6.99 h (3H); 7.17 t (2 H); 7.76 S (6H); 8.22 m (2H); 8.58 broad (2H). 1.3 g (C) gave 0.28 g of 4-12-aminoethoxy7-N, N-dimethylbenzenemethanamine with a boiling point of 90 ° C at 0.04 mm Hg. Rf = 0.2 by thin layer chromatography on silica gel; methano1: 0.88 ammonia (80: 1). 7 g (C) gave 2.7 g of 2- (4-aminobutoxy) -N, N-dimethylbenzene methanamine with a boiling point of 90 ° C at 0.07 mm Hg. Rf = 0.2 by thin layer chromatography on silica gel; methanol: 0.88 ammonia (80: 1).
Exemgel F. _ (a) 2-/YÉL(N,N-dimetylaminometyl)fenyl7metyltio7etanamin. . 17,4 g 3-(N,N-dimetylaminometyl)bensenmetanol och 12 g cysteamin-hydroklorid upphettades i koncentrerad saltsyra vid 10000 under 4 timmar. Efter kylning behandlades reaktionsbland- ningen med fast natriumkarbonat och extraherades med eter. De organiska extrakben destillerades, varvid man erhöll 21,5 g av den önskade föreningen i form av en olja med en kokpunkt av 154-158°C vid 1,5 mm Hg. Produktens hydrokloridsalt smälte vid 7805591-Û 20 180-18200. Rf= 0,37 vid tunnskiktskromatografi på silikagel; ety1acetat:isopropanol:vatten:O,88 ammoniak (25:l5:8:2). (b) Utgående från 10,1 g 3-(N-metylaminometyl)bensen- metanol och 7,7 g cysteamin-hydroklorid framställdes på liknande sätt 6,5 g 2-[ZÉL(N-metylaminometyl)fenyl7metyltig7etanamin med en kokpunkt av 140-145°c vid o,o1 mm Hg. Rf= 0,28 vid tunnskikts- kromatografi på silikagel; etylacetat:isopropanol:vatten:0,88 ammo- niak (25:l5:8:2). (c) Utgående från 0,8 g 2-(N,N-dimetylaminometyl)bensen- metanol och 0,57 g cysteamin-hydroklorid framställdes på liknande sätt 0,38 g 2-[ZÉ-(N,N-dimetylaminometyl)fenyl7metyltig7etanamin med en kokpunkt av 100-l05°C vid 0,01 mm Hg. Rf= 0,22 vid tunn- skiktskromatografi på silikagel; etylacetat:metanol:0,88 ammoniak (l0:10:l). _ (d) Utgående från Ä g 4-(N,N-dimetylaminometyl)bensen- metanol och~2,8 g pysteamin-hydroklorid framställdes på liknande sätt 3,6 g 2-¿ZH.ÉN}N-dimetylaminometyl)feny;7mecy1c197euanam1n med en kokpunkt av 148-15000 vid 0,01 mm Hg. 7 " Analys: _ Beräknat för cl2H20N2s= c 64,2 H 9,0 N 12,5 % Funnet: C 63,8 H 9,2 N 12,1 % Exempel G. 3-(N,N-dimetylaminometyl)bensenbutanamin. 5-(N,N-dimetylaminometvl)bensenpropansyra-etylester. 5,5 g jeformylkanelsyra upphettades vid 60°C 1 45 mld av en 30 %-ig etanollösning av dimetylamin under 30 minuter och omrördes sedan vid rumstemperatur med 1,5 g 10 % palladiumoxid på träkol under ett vätgastryck av 1 atmosfär. Sedan upptagning- en av väte hade upphört filtrerades blandningen, och filtratet indunstades. Återstoden kokades under áterflöde 1 etanol och koncentrerad svavelsyra under 4 timmar. Lösningen neutralisera- des sedan med natriumkarbonat och destillerades. Man erhöll här- vid 4,2 g av den.önskade produkten såsom en färglös vätska med en xoxpunkt av 13o°c vid o,o5 mm Hg. ” ie- 0 . N Rf= 0,75 vid tunnskiktskromatografi på silikagel; etyl- acetat;isopropanol:vatten:0,88 ammoniak (25:15:8:2). 3-(N,N-dimetylaminometyl)bensgnprqpanol. 0,5 g 3-(N,N-dimetylamínometyl)bensenpropansyra-etyl- ester och 0,2 g litiumaluminiumhydrid omrördes vid rumstempera- tur i torr tetrahydrofuran under 2 timmar. Reaktionsblandninßflfl 7805591-Û 21 behandlades därefter med vatten och filtrerades. Filtratet in- dunstades, varvid man erhöll 0,34 g av den önskade produkten såsom en färglös vätska.Example Gel F. (a) 2- [YEL (N, N-dimethylaminomethyl) phenyl] methylthio7ethanamine. . 17.4 g of 3- (N, N-dimethylaminomethyl) benzenemethanol and 12 g of cysteamine hydrochloride were heated in concentrated hydrochloric acid at 10,000 for 4 hours. After cooling, the reaction mixture was treated with solid sodium carbonate and extracted with ether. The organic extracts were distilled to give 21.5 g of the desired compound as an oil, b.p. 154-158 ° C at 1.5 mm Hg. The hydrochloride salt of the product melted at 180 DEG-180 DEG-180 DEG. Rf = 0.37 by thin layer chromatography on silica gel; ethyl acetate: isopropanol: water: 0.88 ammonia (25: 15: 8: 2). (b) Starting from 10.1 g of 3- (N-methylaminomethyl) benzenemethanol and 7.7 g of cysteamine hydrochloride, 6.5 g of 2- [ZÉL (N-methylaminomethyl) phenyl] methyltigetanamine with a boiling point of 140 -145 ° C at 0.1 mm Hg. Rf = 0.28 by thin layer chromatography on silica gel; ethyl acetate: isopropanol: water: 0.88 ammonia (25: 15: 8: 2). (c) Starting from 0.8 g of 2- (N, N-dimethylaminomethyl) benzenemethanol and 0.57 g of cysteamine hydrochloride, 0.38 g of 2- [ZÉ- (N, N-dimethylaminomethyl) phenyl] methyltig7ethanamine were prepared in a similar manner with a boiling point of 100-105 ° C at 0.01 mm Hg. Rf = 0.22 by thin layer chromatography on silica gel; ethyl acetate: methanol: 0.88 ammonia (10: 10: 1). (d) Starting from Ä g of 4- (N, N-dimethylaminomethyl) benzenemethanol and 2,2.8 g of pysteamine hydrochloride, 3.6 g of 2-ZZH.ÉN} N-dimethylaminomethyl) pheny were prepared in a similar manner; 7mecy1c197euanamine with a boiling point of 148-15000 at 0.01 mm Hg. 7 "Analysis: Calculated for C 12 H 20 N 2 S = c 64.2 H 9.0 N 12.5% Found: C 63.8 H 9.2 N 12.1% Example G. 3- (N, N-dimethylaminomethyl) benzenebutanamine 5- (N, N-Dimethylaminomethyl) benzenepropanoic acid ethyl ester 5.5 g of jeformyl cinnamic acid were heated at 60 ° C for 45 ml of a 30% ethanol solution of dimethylamine for 30 minutes and then stirred at room temperature with 1.5 g. % palladium oxide on charcoal under a hydrogen pressure of 1 atmosphere After the hydrogen uptake had ceased, the mixture was filtered and the filtrate was evaporated, the residue was refluxed with ethanol and concentrated sulfuric acid for 4 hours. thereby obtained 4.2 g of the desired product as a colorless liquid with a xox point of 130 DEG C. at 0.5 mm Hg. isopropanol: water: 0.88 ammonia (25: 15: 8: 2) 3- (N, N-dimethylaminomethyl) benzopropanol 0.5 g 3- (N, N-dimethylaminomethyl) benzenepropane acid-ethyl ester and 0.2 g of lithium aluminum hydride were stirred at room temperature in dry tetrahydrofuran for 2 hours. Reaction mixture flfl 7805591-Û 21 was then treated with water and filtered. The filtrate was evaporated to give 0.34 g of the desired product as a colorless liquid.
Rf= 0,7 vid tunnskiktskromatografi på silikagel; etyl- acetatzisopropanol:vatten:O,88 ammoniak (25:l5:8:2). NMR (CDCl5): 2,81 m (4H); 6,33 tr (2H); 6,59 S (2H); 7,28 m (2H); 7,75 S (7H); 7,7-8,h m (en). 3-(N,N-dimetylaminometyl)bensenbutannitril. 0,9 g 5-(N,N-dimetylaminometyl)bensenpropanol och(L9 g p-toluensulfonylklorid omrördes i pyridin under 2 timmar. Lösnings- medlet avdunstades därefter, och återstoden behandlades med 0,7 g kaliumcyanld 1 dimetyiformamid vid 45°c under 16 simmar. Därefter tillsattes vatten, och den resulterande blandningen extraherades med etylacetat. Extraktet destillerades, varvid man erhöll 0,3 g av den önskade produkten såsom en färglös vätska med en kokpunkt av 11o°c vid o,o2 mm Hg.Rf = 0.7 by thin layer chromatography on silica gel; ethyl acetate isopropanol: water: 0.88 ammonia (25: 15: 8: 2). NMR (CDCl 5): 2.81 m (4H); 6.33 tr (2H); 6.59 S (2H); 7.28 m (2 H); 7.75 S (7H); 7.7-8, h m (en). 3- (N, N-dimethylaminomethyl) benzenesbutanenitrile. 0.9 g of 5- (N, N-dimethylaminomethyl) benzenepropanol and (L9 g of p-toluenesulfonyl chloride were stirred in pyridine for 2 hours. The solvent was then evaporated, and the residue was treated with 0.7 g of potassium cyanide 1 dimethiformamide at 45 ° C under Then water was added and the resulting mixture was extracted with ethyl acetate, the extract was distilled to give 0.3 g of the desired product as a colorless liquid with a boiling point of 110 ° C at 0.2 mm Hg.
Rf= 0,75 vid tunnskiktskromatografi på silikagel; etyl- acetat:isopropanol:vatten:0,88 ammoniak (25:l5:8:2). 3-(N,N-dimetylaminometyl)bensenbutanamin. 0,9 g 3-(N,N-dimetylaminometyl)bensenbutannitril och 0,É5 g litiumaluminiumhydrid omrördes i tetrahydrofuran vid rums- temperatur under 2 timmar. Vatten tillsattes därefter, och den erhållna suspensionen filtrerades. Filtratet indunstades, varvid man erhöll 0,8 g av den önskade föreningen såsom en färglös olja.Rf = 0.75 by thin layer chromatography on silica gel; ethyl acetate: isopropanol: water: 0.88 ammonia (25: 15: 8: 2). 3- (N, N-dimethylaminomethyl) benzenebutanamine. 0.9 g of 3- (N, N-dimethylaminomethyl) benzenesbutanitrile and 0.5 g of lithium aluminum hydride were stirred in tetrahydrofuran at room temperature for 2 hours. Water was then added, and the resulting suspension was filtered. The filtrate was evaporated to give 0.8 g of the desired compound as a colorless oil.
Rf= 0,1 vid tunnskiktskromatografi på silikagelg etyl- acetat:isopropanolÉvatten:0,88 ammoniak (25:l5:8:2). Föreningens oxaiecsaiu smälter vid 125-127°c.Rf = 0.1 by thin layer chromatography on silica gel ethyl acetate: isopropanolEwater: 0.88 ammonia (25: 15: 8: 2). The oxaiecsaiu of the compound melts at 125-127 ° c.
Exemnel l. (a) N-mety1-N'-/3-/3;(N,N-aimegyiaminometyl)renex17- propyl7-2-nitro-1,1-etendiamin.Example 1. (a) N-methyl-N '- [3- [3; (N, N-methylaminomethyl) renex17-propyl] -2-nitro-1,1-ethenediamine.
En blandning av l g 3-(3-aminopropoxi)-N,N-dimetylbonsen- metanamin och 0,78 g N-metyl-2-nitroimidotiosyra-metylester i 4 ml vatten omrördes vid rumstemperatur under 4 timmar. Den resul terande lösningen surgjordes med isättika och tvättades därefter med etylacetat. Den sura lösningen alkaliserades med natriumkar- ' bonat och extraherades med etylacetat. Extraktet torkades över magnesiumsulfat, filtrerades och indunstades till en olja, vilken kristalliserade i eterlösning. Man erhöll 0,6 g av den önskade föreningen såsom ett vitt fast ämne med en smältpunkt av 81-8300. 7805591-0 22 Rf= 0,6 vid tunnskiktskromatografi på silikagel; etylacetatziso- propanol:vatten:0,88 ammoniak (25:l5:8:2).A mixture of 1 g of 3- (3-aminopropoxy) -N, N-dimethylbonsenemethanamine and 0.78 g of N-methyl-2-nitroimidothioic acid methyl ester in 4 ml of water was stirred at room temperature for 4 hours. The resulting solution was acidified with glacial acetic acid and then washed with ethyl acetate. The acidic solution was alkalized with sodium carbonate and extracted with ethyl acetate. The extract was dried over magnesium sulfate, filtered and evaporated to an oil which crystallized in ether solution. 0.6 g of the desired compound was obtained as a white solid, m.p. 81-8300. 7805591-0 22 Rf = 0.6 by thin layer chromatography on silica gel; ethyl acetate isopropanol: water: 0.88 ammonia (25: 15: 8: 2).
De nedan angivna föreningarna framställdes på. lilmande sätt utgående från motsvarande diamin och N-mety1-2-nitroimido- tiosyra-metylester (D). (b) (0) (6) (e) (f) (s) 2 g diamin och 1,4 g (D) gav 0,8 g N-metyl-N'-¿§- -[Z3-(N-metylaminometyl)fenyl7mety1tig7ëtyl7-2- -nitro-1,1-etendiamin. Rf= 0,3 vid tunnskiktskroma- tografi på silikagel; metanol:ammoniak (50:1). vFöreningens fumaratsalt smälter vid 163-l65°C. 1 g diamin och 0,75 g (D) gav 0,25 g N-metyl-N'- -¿3-[Z3-(N,N-dimetylaminometyl)fenyl7bi97bropyl7- -2-nifir0-l,l-etendiamin. NMR (CDCl ): O,5-0,5 brm (1H); 2,5-3 m (4H); 3,4 s (lH); 6,2-6,8 m (4H); 6,8-7,4 m (5H); 7,72 S (6H); 8,02 m (EH). 2,5 g diamin plus 1,8 g (D) gav 0,35 g N-metyl-N'- -¿§;¿É;(N-metylaminometyl)fenoxi7bropyl7-2-nítro- -1,1-efienaiamin; Rf= 0,35 vid nunnskixnskromacogra- fi på silikagel; metanol:O,88 ammoniak (20:1).The compounds listed below were prepared on. fragrant starting from the corresponding diamine and N-methyl-2-nitroimido-thioacid methyl ester (D). (b) (0) (6) (e) (f) (s) 2 g of diamine and 1.4 g of (D) gave 0.8 g of N-methyl-N'-β- - [Z3- (N) -methylaminomethyl) phenyl7methyl] ethyl7-2- -nitro-1,1-ethenediamine. Rf = 0.3 in thin layer chromatography on silica gel; methanol: ammonia (50: 1). The fumarate salt of the compound melts at 163-165 ° C. 1 g of diamine and 0.75 g of (D) gave 0.25 g of N-methyl-N'--3- [Z3- (N, N-dimethylaminomethyl) phenyl] bi97bropyl7- -2-nitro-1,1-ethylenediamine. NMR (CDCl 3): 0.5-0.5 brm (1H); 2.5-3 m (4H); 3.4 s (1H); 6.2 - 6.8 m (4H); 6.8 - 7.4 m (5H); 7.72 S (6H); 8.02 m (EH). 2.5 g of diamine plus 1.8 g of (D) gave 0.35 g of N-methyl-N'-α, (N-methylaminomethyl) phenoxy7bropyl7-2-nitro-1,1-e-enamine; Rf = 0.35 in nunnchix chromatography on silica gel; methanol: 0.88 ammonia (20: 1).
NM (cDc15): 2,68 m (2H); 2,9-3,4 m (3H); 5,9 t (2H); 6,29 s (2H); 6,55 u (2H); 7,12 br.s (3H); 7,58 s (3H); 7,62-8,2 m (en). 0,45 g diamin plus 0,24 g (D) gav 0,35 g N-mebyl-N'- -ÅÉ-ÄÉ-(1-pyrrolidinylmetyl)fenoxi7bropyl7¥2-nitro- -1,1-etendiamin. Rf= 0,35 vid tunnskiktskromabogra- fi på silikagel¿ metanol:0,88 ammoniak (80:l). NMR (cnc13); 2,8 m (1H); 2,9-5,5 m (4H); 5,90 u (an), 6,4 s (2H); 6,50 m (2H); 7,1 br (ÄH), 7,5-8,3 m (TH). _ 0,8 g diamin plus 0,78 g (D) gav 0,55 g N-metyl-N'- .¿§.¿5_(N,N-dimetyiaminomeuyl)fenox;7ëuy¿7-2-n1tro- -1,1-esendiamin med en smälupunku av 130-131°c.NM (cDc15): 2.68 m (2H); 2.9 - 3.4 m (3H); 5.9 h (2H); 6.29 s (2 H); 6.55 h (2H); 7.12 br.s (3H); 7.58 s (3 H); 7.62-8.2 m (en). 0.45 g of diamine plus 0.24 g of (D) gave 0.35 g of N-methyl-N'--α-EE- (1-pyrrolidinylmethyl) phenoxy7bropyl-2-nitro-1,1-ethylenediamine. Rf = 0.35 in thin-layer chromatography on silica gel methanol: 0.88 ammonia (80: 1). NMR (cnc13); 2.8 m (1H); 2.9 - 5.5 m (4H); 5.90 h (an), 6.4 s (2H); 6.50 m (2 H); 7.1 br (HH), 7.5-8.3 m (TH). 0.8 g of diamine plus 0.78 g of (D) gave 0.55 g of N-methyl-N'-. (5, (N, N-dimethylaminomethyl) phenox; 7-yl] -2-nitro- 1,1-esenediamine with a melting point of 130-131 ° C.
Hf= 0,3 vid tunnskiktskromafiografi på silikagel; metanol:0,88 ammoniak (80:1). 0,7 g diamin plus 0,52 g (D) gav 0,38 g N-metyl-N'- -[E-ÅÉ;(N,N-dimotylaminomatyl)fenoxi7butyl7-2-nitro- -1,1-etendiamin. Rf= 0,34 vid tunnskiktskromatogra- fi på silikagel; metanol:0,88 ammoniak (80:1).NMR (cnc13)= 0,3 bf (1H); 2,82 t (1H); 3,0-3,5 m (5H); (1) (K) (1) (m) (H) (0) 7805591-Û 23 6,08 br (2H); 6,67 m (nn), 7,15 br (3H); 7.81 S (6H); 8,2 br (4H). 0,6 g diamin plus 0,ä6 g (D) gav 0,58 g N-metyl-N'- -¿3-¿§-(N,N-dimetylaminoetyl)fenoxi7propy¿7-2-nitro -1,1-ecendiamin med en smäivpunxu av 93-94°c. Rf= 0,45 vid tunnskiktskromatografi pá silikagel; etyl- acetat:isopropanol:vatten:0,88 ammoniak (25:15:8:2). 0,5 g diamin plus 0,56 g (D) gav 0,12 g N-mety1-N'- -¿F-¿3-(N,N-dimetylaminoetyl)Ianoxi7butyl7-2-nitro- -1,1-ecendiamin med en smälupunuc av 59-65°c. Rr= 0,4 vid tunnskiktskromatografi på silikagel; etyl- acetat:1sopropanol:vatten:0,88 ammoniak (25:15:8:2). 0,26 § diamin plus 0,22 g (D) gav 0,2 g N-metyl-N'- -¿2~[}-(N,N-dimetylaminopropyl)fenoxi7etyl7~2-nitro- -1,1-etendiamin med en smältpunkt av 82-85,500. Rf= 0,4 vid tunnskiktskromatografi på silikagel; etyl- acetat:vatten:isopropanol:0,88 ammoniak (25:8:15:2). 0,2 g diamin plus 0,15 g (D) gav 0,14 5 N-metyl-N'- -15-15-(N,N-dimetylaminopropyl)fenoxi7propyl7-2-nitro- -1,1-euendiamin med en smaicpunkv av 59,5-61°c. Rf= 0,55 vid tunnskiktskromatografi på silikagel; etyl- acetat:vatten:isopropanol:0,88 ammoniak (25:8:15:2). 0,5 g diamin plus 0,56 g (D) gav 0,45 g N-metyl-N'- -¿É~¿É-(N,Nfdimetylaminopropyl)fenoxl7butylZ-2-nitro- 1,1-ecendiamin med en smäinpunuu av 79-8o,5°c. Rr= 0,5 vid tunnskiktskromatografi på silikagel; etyl- acetatzvatten:isopropanol:0,88 ammoniak (25:8:15:2). 0,28 g diamin plus 0,5 g (D) gav 0,11 g N-metyl-N'¿ -¿§-¿ï-(N,N-dimetylaminometyl)fenox;7etyl7-2~nitro- -1,1-etendiamin med en smältpunkt av 1ü1-142°C. Rf= 0,39 vid tunnskiktskromatografi på silikagel;meta- nol:O,88 ammoniak (50:1). 0,56 g diamin plus 1,19 g (D) gav 0,12 g N-metyl~N'- -15-ÅÉ-(N,N-dimetylamínometyl)fenoxi7propyl7-2-nitro- -1,1-etendiamin med en smältpunkt av 135-15600. Rf= 0,5 vid tunnskiktskromatografi på silikagel; metanol: 0,88.ammoniak (19:1). 0,45 g diamin plus 0,3 g (D) gav 0,25 g N-metyl-N'- -[Ä-ÅÉ-(N,N-dimetylaminoetyl)fenoki]butyl7-2-nitro- 7805591-0 24 1,1-etendiamin med en smältpunkt av 98-100°C. Rf= 0,45 vid tunnskiktskromatografi på silikagel; meta- nol:O,88 ammoniak (80:1). (p) 2,5 g diamin plus 2,0 g (D) gav 1,9 g N-metyl~N'- -¿š-¿ä-(N,N-dimetyiaminomecyi)fenox¿7butyi7-2-n1cro- -1,1-etendiamin med en smältpunkt av 98,5-100°C.Hf = 0.3 for thin-layer chromium fi graph on silica gel; methanol: 0.88 ammonia (80: 1). 0.7 g of diamine plus 0.52 g of (D) gave 0.38 g of N-methyl-N'- - [E-ÅE; (N, N-dimethylaminomatyl) phenoxy] butyl] -2-nitro--1,1-ethylenediamine . Rf = 0.34 by thin layer chromatography on silica gel; methanol: 0.88 ammonia (80: 1). NMR (cnc13) = 0.3 bf (1H); 2.82 t (1 H); 3.0-3.5 m (5H); (1) (K) (1) (m) (H) (0) 7805591-23 23 6.08 br (2H); 6.67 m (nn), 7.15 br (3H); 7.81 δ (6 H); 8.2 br (4H). 0.6 g of diamine plus 0.6 g (D) gave 0.58 g of N-methyl-N'-β-β- (N, N-dimethylaminoethyl) phenoxy] propyl] -2-nitro-1,1 -ecenediamine with a melting point of 93-94 ° C. Rf = 0.45 by thin layer chromatography on silica gel; ethyl acetate: isopropanol: water: 0.88 ammonia (25: 15: 8: 2). 0.5 g of diamine plus 0.56 g (D) gave 0.12 g of N-methyl-N'--β-β- (N, N-dimethylaminoethyl) Ianoxy7butyl7-2-nitro--1,1- ecendiamine with a melting point of 59-65 ° C. Rr = 0.4 by thin layer chromatography on silica gel; ethyl acetate: 1sopropanol: water: 0.88 ammonia (25: 15: 8: 2). 0.26 § diamine plus 0.22 g (D) gave 0.2 g of N-methyl-N'-β2 [[ ethylenediamine with a melting point of 82-85,500. Rf = 0.4 by thin layer chromatography on silica gel; ethyl acetate: water: isopropanol: 0.88 ammonia (25: 8: 15: 2). 0.2 g of diamine plus 0.15 g (D) gave 0.14 N-methyl-N'- -15-15- (N, N-dimethylaminopropyl) phenoxy] propyl 7-2-nitro--1,1-euenediamine with a melting point of 59.5-61 ° C. Rf = 0.55 by thin layer chromatography on silica gel; ethyl acetate: water: isopropanol: 0.88 ammonia (25: 8: 15: 2). 0.5 g of diamine plus 0.56 g of (D) gave 0.45 g of N-methyl-N'-N-N- (N, N-dimethylaminopropyl) phenoxy] butylZ-2-nitro-1,1-ecenediamine with a smäinpunuu of 79-8o, 5 ° c. Rr = 0.5 by thin layer chromatography on silica gel; ethyl acetate waters: isopropanol: 0.88 ammonia (25: 8: 15: 2). 0.28 g of diamine plus 0.5 g of (D) gave 0.11 g of N-methyl-N'¿ -β- (N, N-dimethylaminomethyl) phenoxylethyl-2-nitro-1, 1-ethylenediamine with a melting point of 1ü1-142 ° C. Rf = 0.39 by thin layer chromatography on silica gel, methanol: 0.88 ammonia (50: 1). 0.56 g of diamine plus 1.19 g (D) gave 0.12 g of N-methyl-N'- -15-ÅE- (N, N-dimethylaminomethyl) phenoxy] propyl 7-2-nitro--1,1-ethylenediamine with a melting point of 135-15600. Rf = 0.5 by thin layer chromatography on silica gel; methanol: 0.88 ammonia (19: 1). 0.45 g of diamine plus 0.3 g of (D) gave 0.25 g of N-methyl-N'- - [N-alE- (N, N-dimethylaminoethyl) phenoxy] butyl7-2-nitro-7805591-0 24 1,1-ethylenediamine with a melting point of 98-100 ° C. Rf = 0.45 by thin layer chromatography on silica gel; methanol: 0.88 ammonia (80: 1). (p) 2.5 g of diamine plus 2.0 g of (D) gave 1.9 g of N-methyl-N'-β-α- (N, N-dimethylaminomecyl) phenoxylbutyl-2-n-hydroxy- -1,1-ethylenediamine with a melting point of 98.5-100 ° C.
Rf= 0,45 vid tunnskiktskromatografi på silikagel; metanolzammoniak (80:1). (q) 0,7 g diamin plus 0,44 g (D) gav 0,4 g N-metyl-N'- -14-ÅÉ-(N,N-dimetylaminometyl)fenyl7butyl7-2-nitro- -1,1-etendiamín, vars dihydroklorid smälte vid 137- 139°c. Rr= 0,5 vid cunnskiktsxromacøgrafi på 5111142.- gel; etylacetatzisopropanol:vatten:O,88 ammoniak (25:15:8:2).Rf = 0.45 by thin layer chromatography on silica gel; methanol ammonia (80: 1). (q) 0.7 g of diamine plus 0.44 g of (D) gave 0.4 g of N-methyl-N'- -14-ÅE- (N, N-dimethylaminomethyl) phenyl7butyl7-2-nitro--1,1 -ethenediamine, whose dihydrochloride melted at 137-139 ° C. Rr = 0.5 in cunn layer xromacography on 5111142.- gel; ethyl acetate isopropanol: water: 0.88 ammonia (25: 15: 8: 2).
Exempel 2. N-nitro-N'-/É fenoxizgrogylzguanidin. 0,77 g N-nitrokarbamimidotíosyra-metylester och 1,0 g 3-(}~aminopropoxi)-N,N-dimetylbensenmetanamin uppbettades i eta- nol vid 40°C under 20 minuter. Lösningen kyldes därefter för ut- fällning av titelföreningen, vilken avfiltrerades och omkristalli- serades i etylacetat. Man erhöll härvid 0,44 g produkt såsom ett vitt fast ämne med en smältpunkt av 114-115°C. Rf= 0,48 vid tunn- skiktskromatografi pà silikagel; metanol:O,88 ammoniak (80:1).Example 2. N-nitro-N '- / E phenoxysgrogylzguanidine. 0.77 g of N-nitrocarbamimidothioic acid methyl ester and 1.0 g of 3- (aminopropoxy) -N, N-dimethylbenzenemethanamine were charged with ethanol at 40 ° C for 20 minutes. The solution was then cooled to precipitate the title compound, which was filtered off and recrystallized from ethyl acetate. This gave 0.44 g of product as a white solid, m.p. 114-115 ° C. Rf = 0.48 by thin layer chromatography on silica gel; methanol: 0.88 ammonia (80: 1).
Exempel 3. N-/š-/ÉJN,N-dimetyiaminometyijfenoxiharopyiZ- guanidin-dinitrat. 2 g 3-(5-aminopropoxi)-N,N-dimetylbensenmetanamin och 2,1 g 3,5-dimetylpyrazol-1-karboxamidin-nitrat kokades under åter- flöde 1 etanol under 16 timmar. Lösningsmedlet avlägsnades däref- ter, och återstoden tvättades med kokande etylacetat, varefter den kristalliserades i etanol. Härvid erhölls 1 g av den önskade före- ningen såsom ett vitt fast ämne med en smältpunkt av 123-124°C.Example 3. N- / - / EJN, N-dimethylaminomethylphenoxyharopyl-guanidine dinitrate. 2 g of 3- (5-aminopropoxy) -N, N-dimethylbenzenemethanamine and 2.1 g of 3,5-dimethylpyrazole-1-carboxamidine nitrate were refluxed in ethanol for 16 hours. The solvent was then removed, and the residue was washed with boiling ethyl acetate, after which it was crystallized from ethanol. This gave 1 g of the desired compound as a white solid, m.p. 123-124 ° C.
Rf= 0,34 vid tunnskiktskromatografi på silikagel; etylace- tatzisopropanol:vatten:0,88 ammoniak (25:15:8:2).Rf = 0.34 by thin layer chromatography on silica gel; ethyl acetate-isopropanol: water: 0.88 ammonia (25: 15: 8: 2).
Exemgel 4. (a) N-cyan-N'-metyl-N"-/É-/É-(N,N-dimetylaminometyl)- Qgnoxizgrogvlzguanidin. 0,8 g N-cyan-N'-metylkarbamimidotiosyra-metylester och '1,0 g EÄÄÉ-aminopropoxi7-N,N-dimetylbensenmetanamin upphettades tillsammans vid 100°C under 12 timmar. Smältan'kyldes därefter __..:__..__....__.._._._._. 7805591-0 25 och löstes 1 metanol. Den erhållna lösningen filtrerades, och fil- tratet indunstades. Återstoden renades genom kolonnkromatografi på kiseldioxid, varvid man eluerade med metanol. Man erhöll här- vid 0,5H g av den önskade föreningen såsom en klargul olja. Rf= 0,51 vid tunnskiktskromatografi på silikagel; metanol:O,88 ammo- niak (80:1).Example Gel 4. (a) N-cyano-N'-methyl-N "- [N- [N- (N, N-dimethylaminomethyl) -gnoxysgroglyzguanidine. 0.8 g of N-cyano-N'-methylcarbamimidothioic acid methyl ester and 1.0 g of ε 4 -aminopropoxy7-N, N-dimethylbenzenemethanamine were heated together at 100 DEG C. for 12 hours, then melted and cooled. The resulting solution was filtered, and the filtrate was evaporated, the residue was purified by column chromatography on silica, eluting with methanol to give 0.5H g of the desired compound as a clear yellow oil. Rf = 0.51 by thin layer chromatography on silica gel, methanol: 0.88 ammonia (80: 1).
Analys: Beräknat för c15H23N5o= c 62,28 H 7,96 N 24,22 % Funnet: C 62,54 H 8,51 N 23,93 (b) Utgående från 5 g av motsvarande amin och 2,8 g N-cyan-N'-metylkarbamimidotiosyra~metylester framställdes på lik- nande sätt 2,3 g N-cyan-N'-metyl-N"~¿É-[27-(N,N~dimetylaminometyl) fenyl7metyltig7etyl7guanidin. Rf= 0,47 vid tunnskiktskromatogrnfí på siiikagel; metanol. NM (cncl )= 2,5-5 m (4H); 6,25 s (2H); 6,5-6,9 m (4H); 7,18 d (3H); 7-7,5 m (2H); 7,73 S (6H)- (c) Utgående från 1,5 g av motsvarande amin och 0,86 g av samma ester som ovan framställdes på liknande sätt 1,1 g N-cyan-N'-metyl-N"-[É~[Z§-(N,N-dimetylaminometyl)fenyl7metyltig74 etyl7guanidin med en smältpunkt av 107-108,5°C.Analysis: Calculated for c 15 H 23 N 5 O = c 62.28 H 7.96 N 24.22% Found: C 62.54 H 8.51 N 23.93 (b) Starting from 5 g of the corresponding amine and 2.8 g of N- Cyano-N'-methylcarbamimidothioic acid methyl ester was similarly prepared in 2.3% 2.3 g of N-cyano-N'-methyl-N "- [27- (N, N-dimethylaminomethyl) phenyl] methyltigetethyl7guanidine. Rf = 0.47 at thin layer chromatography on silica gel; methanol NM (cncl) = 2.5-5 m (4H); 6.25 s (2H); 6.5-6.9 m (4H); 7.18 d (3H); 7-7.5 m (2H); 7.73 S (6H) - (c) Starting from 1.5 g of the corresponding amine and 0.86 g of the same ester as above, 1.1 g of N- cyano-N'-methyl-N "- [~- [Z§- (N, N-dimethylaminomethyl) phenyl] methyl] 74 ethylguanidine having a melting point of 107-108.5 ° C.
Exempel 5. N-metyl-N'-/É-/É-(N,N-dimetylaminometyl)- fgnoxizgropylzkarbamid. 0,27 ml metylisocyanat och 0,97 g 3~(}-aminopropoxi)-N,N- -dimetylbensenmetanamin omrördes vid rumstemperatur 1 acetonitril under 2 timmar. Den bildade titelföreningcn avfiltrerades därefter, tvättades med acetonitríl och omkristallísenades i etylaetat. Man erhöll 0,49 g produkt i form av färglösa prismor med en smältpunkt av 79,5-80°C. Rf= O,U5 vid tunnskiktskromatografi på silikagel; metanol:O,88 ammoniak (80:1).Example 5. N-methyl-N '- / E- / É- (N, N-dimethylaminomethyl) -phenoxysgropylzurea. 0.27 ml of methyl isocyanate and 0.97 g of 3 - (} - aminopropoxy) -N, N- -dimethylbenzenemethanamine were stirred at room temperature in acetonitrile for 2 hours. The title compound formed was then filtered off, washed with acetonitrile and recrystallized from ethyl acetate. 0.49 g of product were obtained in the form of colorless prisms with a melting point of 79.5-80 ° C. Rf = 0.1, by thin layer chromatography on silica gel; methanol: 0.88 ammonia (80: 1).
Exempel 6. N-mety1-N-/§-/7§-(N,N-dímetylaminometyl)- feny17mety1t1o7ety17tiøkarbamia. 1,5 g 2-[Z§-(N,N~dimetylaminometyl)fenyl7metyltig7etan- amin och 0,5 ml metylisotiocyanat omrördes vid rumstemperatur i acetonitril under 6 timmar. Lösningsmedlet avlägsnades därefter, och återstoden underkastades kolonnkromatografi pà silikagel med användning av en blandning av etylacett och metanol såsom elue- ringsmedel. Man erhöll härvid 1 g av den önskade föreningen såsom ett vitt fast ämne med en smältpunkt av 57-59°C.Example 6. N-methyl-N- / §- / 7§- (N, N-dimethylaminomethyl) -phenylmethyl-thio7ethylthiourea. 1.5 g of 2- [2α- (N, N-dimethylaminomethyl) phenyl] methyltigetanamine and 0.5 ml of methyl isothiocyanate were stirred at room temperature in acetonitrile for 6 hours. The solvent was then removed, and the residue was subjected to column chromatography on silica gel using a mixture of ethyl acetate and methanol as eluent. This gave 1 g of the desired compound as a white solid, m.p. 57-59 ° C.
Analys: Beräknat för c14n2}N5s= c 56,5 H'7,8 N 14,1 % 7805591-0 26 Funnet: _ C 56,2 H 8,1 N 13,8 % Emamel 7.la)Nzmštvl-N'-/5-/7?-(N.N-dimetvlaminometvl)- -~fenyl7metyltio7etyl7-2-nitro-1,1-etendiamin. 5 g 2-[Z5-(N,N-dimetylaminometyl)fenyl7mety1tig7etanamin och 2,2 g 1-nitro-2,2-bis(metyltio)eten kokades under àterflöde 1 acetonitril under 7 timmar. Lösningsmedlet avlägsnades därefter, och den kvarvarande oljan användes utan ytterligare rening. Oljan behandlades med 54 ml av en 55 %-ig etanollösning av metylamin och kokades under återflöde 1 5 timmar. Lösningsmedlet avlägsnades, ocn den kvarvarande oljan renades genom kolonnkromatografi på sili kagel, varvid metanol användes såsom elueringsmedel. Den resultera de orangefärgade oljan revs med eter, varvid man erhöll 0,25 g_av den önskade föreningen såsom ett vitt kristallint fast ämne med en smältpunkt av 62-64°C. Rf= 0,56 vid tunnskiktskromatografi på silikagel; etylacetatzisopropanol:vatten:O,88 ammoniak (25:15:8:2) (b)Utgående från 5 g av motsvarande amin och 2,2 g 1-nitro- -2,2-bis(metyltio)eten framställdes på liknande sätt 2,5 g N-metyla -N'-¿ä-¿ZE~(N,N-dimeuylaminometyi)~feny;7mecy1:i37euy¿7-2-nitro- -1,1-etendiamin med en smältpunkt av 98,5-100°C.Analysis: Calculated for c14n2} N5s = c 56.5 H'7.8 N 14.1% 7805591-0 26 Found: _ C 56.2 H 8.1 N 13.8% Emamel 7.la) Nzmštvl-N 1- [5- [7- (NN-dimethylaminomethyl) -phenyl] methylthio] ethyl] -2-nitro-1,1-ethenediamine. 5 g of 2- [Z5- (N, N-dimethylaminomethyl) phenyl] methyl] ethanamine and 2.2 g of 1-nitro-2,2-bis (methylthio) ethylene were refluxed in acetonitrile for 7 hours. The solvent was then removed, and the residual oil was used without further purification. The oil was treated with 54 ml of a 55% ethanol solution of methylamine and refluxed for 5 hours. The solvent was removed and the residual oil was purified by column chromatography on silica gel using methanol as eluent. The resulting orange oil was triturated with ether to give 0.25 g of the desired compound as a white crystalline solid, m.p. 62-64 ° C. Rf = 0.56 by thin layer chromatography on silica gel; ethyl acetate isopropanol: water: 0.88 ammonia (25: 15: 8: 2) (b) Starting from 5 g of the corresponding amine and 2.2 g of 1-nitro--2,2-bis (methylthio) ethylene were prepared in a similar manner 2.5 g of N-methyl-N'-α-εZE- (N, N-dimethylaminomethyl) -phenyl; 7-methyl: 37-ethyl-2,2-nitro-1,1-ethylenediamine with a melting point of 98.5 -100 ° C.
Analys: Beräknat,för C15H2¿N4O2: C 55,5 H 7,45 N 17,5 ß Funnet: C 55,45 H 7,4 N 17,1 % Exemgel 8. (a) Ng/5-/5-(N,N-dimetylaminometyl)fenoxi7propyl7-N'- ' -(2-metox1ecy1)~2-nitro-1,1-etendiamin-hydrokloria. (1) Ne/5-/5-(N,N-dimetylamin>metyl)fenox17propyl7- -2-nitroimidotiosyra-metylester. 10 g 5-(5-aminopropoxi)-N,N-dimetylbensenmetanamin och 16 g 1-nitro-2,2-bis(metyltio)eten kokades under àterflöde i tetrahydrofuran under 19 timmar. Därefter tillsattes 1.5 g oxal- syra-dihydrat, och den resulterande fällningen bortkastades. Lös- ningsmedlet avlägsnades, varvid man erhöll 10 g av den önskade föreningen såsom ett kristallint fast ämne med en smältpunkt av 59-63°c.Analysis: Calculated, for C 15 H 21 N 4 O 2: C 55.5 H 7.45 N 17.5 ß Found: C 55.45 H 7.4 N 17.1% Example gel 8. (a) Ng / 5- / 5- (N, N-dimethylaminomethyl) phenoxy] propyl 7-N '-' - (2-methoxyecyl) -2-nitro-1,1-ethenediamine hydrochloride. (1) Ne / 5- [5- (N, N-dimethylamine> methyl) phenoxypropyl] -2-nitroimidothioic acid methyl ester. 10 g of 5- (5-aminopropoxy) -N, N-dimethylbenzenemethanamine and 16 g of 1-nitro-2,2-bis (methylthio) ethylene were boiled under reflux in tetrahydrofuran for 19 hours. Then 1.5 g of oxalic acid dihydrate was added, and the resulting precipitate was discarded. The solvent was removed to give 10 g of the desired compound as a crystalline solid, m.p. 59-63 ° C.
Analys: Beräknat för C15H23N3O5S: C 55,55 H 7,05 N 12,9 ß Funnet= c 54,95 H 7,15 N 12,95 % (2) N;/5-/5-(n,N-aimecyiaminømecyl)fenox17propy17- -N'-(2-metoxietyl)-2-nitro-1,I-etendiamin-hydro- klorid. ' 7805591~D 27 En blandning av 0,8 g N-¿š-¿š-(N,N-dimetyiaminometyi)- fenoxi7propyl7-2-nitroimidotiosyra-metylester och 0,2 g 2-metoxi- etylamin omrördes vid rumstemperatur i etanol under 24 timmar. Lös- ningsmedlet avlägsnades därefter, varvid man erhöll en orangefärgad olja, vilken behandlades med en otanollösning av väteklorid. Härvid whölls 0,4 g av den önskade föreningen med en smältpunkt av 109-1126 Analys: Beräknat för C17H28Nu0n: C 52,5 H 7,45 N 14,4 % Funnet: C 52,1 H 7,7 N 14,0 % De nedan angivna föreningarna framställdes på liknande sätt utgående från estern och motsvarande amin. (2)(b) 0,8 g ester plus 3 ml av en 70 %-ig vatten- lösning av etylamin gav 0,69 g N-etyl~N'-Ä?-ÅÉ-(N,N-dimetylamino- metyl)fenoxi7propyl7-2-nitro-1,1-etendiamin-hydroklorid med en smältpunkh av 144-145°c. Rr= 0,55 vid tunnskiktsxrnmatognari pa silikagel; etylacetatzisopropanol:vatten:O,88 ammoniak (25:15:8:2). (2)(o) 0,8 g ester plus 0,5 ml 0,88 ammoniak gav 0,6 g N-[É-[É-(N,N-dimetylaminometyl)fenoxi7propyl7-2-nitro-1,1- etendiamin-hydroklorid med en smältpunkt av 100-10200. Hf= 0,65 vid tunnskiktskromatografi på silikagel; etylacetatzisopropanolz vatten:0,88 ammoniak (25:15:8:2).Analysis: Calculated for C 15 H 23 N 3 O 5 S: C 55.55 H 7.05 N 12.9 ß Found = c 54.95 H 7.15 N 12.95% (2) N; / 5- / 5- (n, N- amylaminoemecyl) phenoxylpropyl17--N '- (2-methoxyethyl) -2-nitro-1,1-ethenediamine hydrochloride. A mixture of 0.8 g of N-β-β- (N, N-dimethylaminomethyl) -phenoxy] propyl] -2-nitroimidothioic acid methyl ester and 0.2 g of 2-methoxyethylamine was stirred at room temperature in ethanol. for 24 hours. The solvent was then removed to give an orange oil which was treated with an otanol solution of hydrogen chloride. 0.4 g of the desired compound with a melting point of 109-1126 was obtained. Analysis: Calculated for C 17 H 28 NuOn: C 52.5 H 7.45 N 14.4% Found: C 52.1 H 7.7 N 14.0 % The compounds listed below were prepared in a similar manner starting from the ester and the corresponding amine. (2) (b) 0.8 g of ester plus 3 ml of a 70% aqueous solution of ethylamine gave 0.69 g of N-ethyl-N'-N? -ÅÉ- (N, N-dimethylaminomethyl) phenoxy7propyl7-2-nitro-1,1-ethylenediamine hydrochloride having a melting point of 144-145 ° C. Rr = 0.55 in thin-layer metal feeders on silica gel; ethyl acetate isopropanol: water: 0.88 ammonia (25: 15: 8: 2). (2) (o) 0.8 g of ester plus 0.5 ml of 0.88 ammonia gave 0.6 g of N- [E- [E- (N, N-dimethylaminomethyl) phenoxy] propyl] -2-nitro-1,1- ethylenediamine hydrochloride having a melting point of 100-10200. Hf = 0.65 by thin layer chromatography on silica gel; ethyl acetate isopropanolz water: 0.88 ammonia (25: 15: 8: 2).
Exempel 9. N-metansulfonyl-N'-metyl-N"-/É-/É-(N,N-dimetyl- aminometyl)fenoxi7propyl7guanidin. 3 g N-metansulfonylkarbonimidoditiosyra-dimetylester och 2,5 g 5-[E-aminopropox;7~N,N-dimetylbensenmetanamin kokades under återflöde i etanol under 4 timmar. Metylamin tillsattes därefter och àterflödeskokningen fortsattes under 1,5 timmar. Lösningsmedlet avlägsnades sedan och återstoden renades genom kolonnkromatografí på silikagel, varvid metanol användes såsom elueringsmedel. Härvid er- hölls 1,9 g av den önskade föreningen såsom ett gult gummi. Rf= 0,65 vid tunnskiktskromatografi på silikagel; metano1:0,88 ammo- niak (8o=1). NM (cnci )= 2,85 m (1H); 2,9-5,5 m (5H); 3,o~4,3 brs (2H); 5,90 t (2H): 6,5 q (2H); 6.6 S (2H); 7,1 S (6H); 7,75 S (6H); 7,9 m (2H)- 5, ' ,H De nya föreningarna med formeln I har visat sig kunna hämma den magsaftsekretion som framkallas av histamin. Detta har påvisats vid försök med råttor enligt en modifikation av den me- tod som beskrivits av M.N. Ghosh och H.0. Schild i British Journal of Pharmacology 19§8, Vol. X5, p. 54. 7805591-0 28 Såsom försöksdjur användes honråttor med.en vikt av ca 150 g. Ràttorna får svälta över natten och ges sedan en 8 %-ig lösning av sackaros i normal saltlösning istället för dricksvatten.Example 9. N-Methanesulfonyl-N'-methyl-N "- [N- [N- (N, N-dimethylaminomethyl) phenoxy] propyl] guanidine. 3 g of N-methanesulfonylcarbonimidodithioic acid dimethyl ester and 2.5 g of 5- [E-aminopropox 7-N, N-dimethylbenzene methanamine was refluxed in ethanol for 4 hours, then methylamine was added and refluxing was continued for 1.5 hours, the solvent was then removed and the residue was purified by column chromatography on silica gel using methanol as eluent. 1.9 g of the desired compound as a yellow rubber, Rf = 0.65 on thin layer chromatography on silica gel, methanol: 0.88 ammonia (80 = 1), NM (cnci) = 2.85 m (1H); 2.9-5.5 m (5H); 3.0-4.3 brs (2H); 5.90 t (2H): 6.5 q (2H); 6.6 S (2H); 7.1 S (6H); 7.75 S (6H); 7.9 m (2H) - 5, ', H The new compounds of formula I have been shown to inhibit the gastric juice secretion induced by histamine, which has been demonstrated in experiments in rats. according to a modification of the method described by MN Ghosh and H.0 Schi ld in British Journal of Pharmacology 19§8, Vol. X5, p. 54. 7805591-0 28 As experimental animals, female rats weighing about 150 g were used. The rats are allowed to starve overnight and then given an 8% solution of sucrose in normal saline instead of drinking water.
Råttorna bedövas genom en enda intraperitoneal injicering av en lösning innehållande 25 g uretan per 100 ml. Uretanlösningen in- Jiceras i en mängd av 0,5 ml per 100 g kroppsvikt. Efter bedövning införes kanyler i luftstrupen och halsvenerna.The rats are anesthetized by a single intraperitoneal injection of a solution containing 25 g of urethane per 100 ml. The urethane solution is injected in an amount of 0.5 ml per 100 g body weight. After anesthesia, needles are inserted into the trachea and jugular veins.
Magsäcken frilägges genom ett snitt mitt i bukväggen, och magsäcken separeras från levern och mjälten genom att de sammanbindande vävnaderna avskäres. En liten öppning göres i den övre säckformiga utvidgningen av magsäcken, och magsäcken tvättas med en 5 %-ig dextroslösning. I matstrupen införes i kanyl bestå- ende av en gummislang, och matstrupen och nerverna avskäres sedan ovanför kanylen. 5 En liten öppning göres därefter i magporten. En stor plexiglaskanyl införes i magsäcken via öppningen i den övre säck- formiga utvidgningen av magsäcken, och denna kanyl placeras pà sådant sätt, att kanylens inloppsände sticker ut ur magsäcken genom öppningen i magporten. Denna kanyl har sådan form, att den minskar magsäckens effektiva volym och åstadkommer en turbulent strömning av perfusionsvätskan över slemhinnan. En dränerings- kanyl införes sedan genom öppningen i den övre säckformiga utvidg- ningen av magsäcken. Báda kanylerna hålles på plats med hjälp av ligaturer anbragta på sådant sätt att de icke kommer i kontakt med huvudblodkärlen. Kanylerna sträcker sig ut genom hål i kroppsvägg- en. Genom kanylerna i matstrupen och magporten ledes en 5 %-ig dextroslösning genom magsäcken. Dextroslösningen har en temperatur av 3900 och strömningshastigheten genom varje kanyl är 1,5 ml per minut. I den utgående dextroslösningen bestämmes pH-värdet.The stomach is exposed through an incision in the middle of the abdominal wall, and the stomach is separated from the liver and spleen by cutting off the connecting tissues. A small opening is made in the upper sac-shaped enlargement of the stomach, and the stomach is washed with a 5% dextrose solution. The esophagus is inserted into a cannula consisting of a rubber tube, and the esophagus and nerves are then cut off above the cannula. A small opening is then made in the stomach port. A large plexiglass cannula is inserted into the stomach through the opening in the upper sac-shaped dilation of the stomach, and this cannula is placed in such a way that the inlet end of the cannula protrudes from the stomach through the opening in the gastric port. This cannula has such a shape that it reduces the effective volume of the stomach and causes a turbulent flow of the perfusion fluid over the mucosa. A drainage cannula is then inserted through the opening in the upper sac-shaped dilation of the stomach. Both cannulas are held in place by means of ligatures arranged in such a way that they do not come into contact with the main blood vessels. The needles extend through holes in the body wall. Through the cannulas in the esophagus and gastric port, a 5% dextrose solution is passed through the stomach. The dextrose solution has a temperature of 3900 and the flow rate through each cannula is 1.5 ml per minute. In the starting dextrose solution, the pH value is determined.
Den normala magsaftsekretionen bestämmes genom att man mäter pH-värdet i perfusionseffluenten. Man framkallar därefter en ökad magsaftsekretion genom en kontinuerlig intravenös infu- sion av en submaximal dos histamin. På detta sätt uppnås en sta- bil förhöjd nivå av magsaftsekretionen, och när detta stabila till- stånd har uppnåtts, mäter man på nytt pH-värdet i perfusionsefflu- enten.Normal gastric juice secretion is determined by measuring the pH of the perfusion effluent. An increased gastric juice secretion is then induced by a continuous intravenous infusion of a submaximal dose of histamine. In this way a stable elevated level of gastric juice secretion is achieved, and when this stable state has been reached, the pH value in the perfusion effluent is measured again.
Man administrerar därefter provförening genom en intra- venös injicering, och den genom denna administrering åstadkomma förändringen av magsaftsekretionen bestämmes genm att man mäter förändringen av perfusionseffluentens pH-värde. 7805591-0 29 Med hjälp av pH-mätningarna beräknas den ökning av magsaft- sekretionen, som âstadkommes medelst histamin, och denna ökning uttryckes såsom mol vätejoner per liter. Den minskning av denna förhöjda magsaftsekretion, som âstadkommes genom administrering av provförening, beräknas också såsom mol vätejoner per liter. Den procentuella minskning av den förhöjda magsaftsekretionen som åstadkommas genom administreringen av provföreningen kan därefter beräknas. Man beräknar EDSO, dvs. den dos av provföreningen som ger en SO-procentig minskning av den förhöjda magsaftsekretionen.The test compound is then administered by an intravenous injection, and the change in gastric juice secreted by this administration is determined by measuring the change in the pH of the perfusion effluent. 7805591-0 29 Using the pH measurements, the increase in gastric secretion effected by histamine is calculated, and this increase is expressed as moles of hydrogen ions per liter. The reduction in this increased gastric juice secretion, which is achieved by administering test compound, is also calculated as moles of hydrogen ions per liter. The percentage reduction in the elevated gastric juice secretion produced by the administration of the test compound can then be calculated. EDSO is calculated, ie. the dose of the test compound that gives an SO% reduction in the increased gastric secretion.
I nedanstående tabell anges EDso-värden för ett antal. representa- tiva föreningar med formeln I.The table below lists ED 50 values for a number. representative compounds of formula I.
Förening enl. exemgel EQSO mglkg 1(a) - 0.10 1(b) I 0.80 Hc) I . 3.3 1(d) 1.1 me) 0.039 ng) 2.7 un) . ' 'om un) i 2.1 2 - ' - 0.62 Mu) ' i 0-67 nå) 'i I 0.9: 9 0.29Association according to exemgel EQSO mglkg 1 (a) - 0.10 1 (b) I 0.80 Hc) I. 3.3 1 (d) 1.1 me) 0.039 ng) 2.7 un). '' om un) i 2.1 2 - '- 0.62 Mu)' i 0-67 nå) 'i I 0.9: 9 0.29
Claims (4)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB20660/77A GB1604674A (en) | 1977-05-17 | 1977-05-17 | Aminoalkyl-benzene derivatives |
GB4012977 | 1977-09-27 | ||
GB1744478 | 1978-05-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7805591L SE7805591L (en) | 1978-11-18 |
SE443558B true SE443558B (en) | 1986-03-03 |
Family
ID=27257503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7805591A SE443558B (en) | 1977-05-17 | 1978-05-16 | PROCEDURE FOR THE PREPARATION OF AMINOAL REFRIGERATIVE SUBSTANCES WITH PHARMACEUTICAL EFFECT |
Country Status (13)
Country | Link |
---|---|
JP (1) | JPS53149936A (en) |
AU (2) | AU523496B2 (en) |
CH (2) | CH643238A5 (en) |
DE (1) | DE2821410A1 (en) |
DK (1) | DK214878A (en) |
ES (1) | ES469953A1 (en) |
FI (1) | FI781490A (en) |
FR (2) | FR2401135A1 (en) |
IE (1) | IE46886B1 (en) |
IT (1) | IT1156755B (en) |
NL (1) | NL7805344A (en) |
NZ (1) | NZ187235A (en) |
SE (1) | SE443558B (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4233302A (en) * | 1977-12-23 | 1980-11-11 | Glaxo Group Limited | Amine derivatives and pharmaceutical compositions containing them |
AR228941A1 (en) * | 1978-04-26 | 1983-05-13 | Glaxo Group Ltd | PROCEDURE FOR PREPARING NEW DERIVATIVES OF 3,5-DIAMINO-1,2,4-TRIAZOLE WHICH ARE ACTIVE AGAINST HISTAMINIC RECEPTORS |
PT70884A (en) * | 1979-03-02 | 1980-03-01 | Glaxo Group Ltd | Process for preparing heterocyclic derivatives |
US4293557A (en) | 1979-07-03 | 1981-10-06 | Teikoku Hormone Mfg. Co., Ltd. | Antiulcer phenoxypropylamine derivatives |
JPS609750B2 (en) * | 1979-07-03 | 1985-03-12 | 帝国臓器製薬株式会社 | Novel N-substituted phenoxypropylamide compounds |
JPS568352A (en) * | 1979-07-03 | 1981-01-28 | Shionogi & Co Ltd | Aminoalkylvenzene derivative |
EP0029303B1 (en) * | 1979-10-22 | 1985-01-30 | Glaxo Group Limited | 1,2,4-triazole derivatives, processes for their production and pharmaceutical compositions containing them |
US4238487A (en) * | 1979-10-31 | 1980-12-09 | Merck & Co., Inc. | Aminoalkyl benzofuran derivatives |
FR2477537A1 (en) * | 1980-03-07 | 1981-09-11 | Francaise Sucrerie | NOVEL ACYLATED GUANIDINES, UREAS AND SUBSTITUTED UREAS, THEIR MANUFACTURING PROCESS AND THEIR APPLICATION AS MEDICAMENTS |
US4490533A (en) * | 1980-12-22 | 1984-12-25 | Merck & Co., Inc. | Aminoalkyl pyridine derivatives |
EP0057981A3 (en) | 1981-02-09 | 1982-08-25 | Beecham Group Plc | Aromatic compounds, processes for their preparation and their use |
JPS57165348A (en) * | 1981-04-06 | 1982-10-12 | Teikoku Hormone Mfg Co Ltd | Novel aminoalkylbenzene derivative |
US4522943A (en) * | 1981-05-18 | 1985-06-11 | Bristol-Myers Company | Chemical compounds |
US4526973A (en) * | 1981-05-18 | 1985-07-02 | Bristol-Myers Company | Chemical compounds |
IE53068B1 (en) * | 1981-06-15 | 1988-05-25 | Merck & Co Inc | Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors |
DE3275291D1 (en) * | 1981-07-24 | 1987-03-05 | Glaxo Group Ltd | Heterocyclic derivatives |
US4411899A (en) * | 1981-12-21 | 1983-10-25 | Merck & Co., Inc. | Substituted derivatives of amino alkane diols as gastric secretion inhibitors |
JPS5988458A (en) * | 1982-11-12 | 1984-05-22 | Toyama Chem Co Ltd | Amine derivative and its salt |
JPH0639466B2 (en) * | 1987-08-03 | 1994-05-25 | 杏林製薬株式会社 | Urea derivative |
JPH01131172A (en) * | 1987-08-28 | 1989-05-24 | Toyama Chem Co Ltd | Amine derivative and salt thereof and antiulcer agent containing said derivative and salt |
EP0641763B1 (en) * | 1992-05-12 | 1997-01-08 | Zeria Pharmaceutical Co., Ltd. | Novel quaternary ammonium salts and use thereof as medicine |
TWI328009B (en) | 2003-05-21 | 2010-08-01 | Glaxo Group Ltd | Quinoline derivatives as phosphodiesterase inhibitors |
AR070950A1 (en) * | 2007-11-01 | 2010-05-19 | Acucela Inc | COMPOUNDS DERIVED FROM AMINA, PHARMACEUTICAL COMPOSITIONS OF THEM, INHIBITING PRODUCTION COMPOUNDS OF 11-CIS-RETINOL AND METHODS TO TREAT DISEASES AND OPHTHALMIC DISORDERS |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE636468A (en) * | ||||
US2785201A (en) * | 1953-12-24 | 1957-03-12 | Personnes A Responsabilite Lim | Compounds of bis quaternary ammonium derivatives of phenylethylamine |
US3047628A (en) * | 1957-02-19 | 1962-07-31 | Hoffmann La Roche | Benzylamine derivatives |
GB993581A (en) * | 1960-03-03 | 1965-05-26 | Wellcome Found | Phenoxyalkylguanidines and their synthesis and pharmaceutical preparations containing them |
GB1338169A (en) * | 1971-03-09 | 1973-11-21 | Smith Kline French Lab | Ureas thioureas and guanidines |
GB1421792A (en) * | 1973-05-17 | 1976-01-21 | Smith Kline French Lab | Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them |
JPS5227757A (en) * | 1975-08-26 | 1977-03-02 | Kyowa Hakko Kogyo Co Ltd | Preparation of 6-aminomethylnaphthalene derivatives |
-
1978
- 1978-05-09 IE IE940/78A patent/IE46886B1/en unknown
- 1978-05-10 NZ NZ187235A patent/NZ187235A/en unknown
- 1978-05-11 FI FI781490A patent/FI781490A/en not_active Application Discontinuation
- 1978-05-12 AU AU36067/78A patent/AU523496B2/en not_active Expired
- 1978-05-16 SE SE7805591A patent/SE443558B/en unknown
- 1978-05-16 DE DE19782821410 patent/DE2821410A1/en not_active Withdrawn
- 1978-05-16 CH CH531578A patent/CH643238A5/en not_active IP Right Cessation
- 1978-05-16 DK DK214878A patent/DK214878A/en unknown
- 1978-05-17 IT IT7849419A patent/IT1156755B/en active
- 1978-05-17 FR FR7814594A patent/FR2401135A1/en active Granted
- 1978-05-17 NL NL7805344A patent/NL7805344A/en not_active Application Discontinuation
- 1978-05-17 ES ES469953A patent/ES469953A1/en not_active Expired
- 1978-05-17 JP JP5870678A patent/JPS53149936A/en active Granted
- 1978-10-03 FR FR7828239A patent/FR2398718A1/en active Granted
-
1982
- 1982-05-25 AU AU84117/82A patent/AU541144B2/en not_active Expired
- 1982-12-22 CH CH749182A patent/CH643233A5/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IE46886B1 (en) | 1983-10-19 |
CH643233A5 (en) | 1984-05-30 |
AU541144B2 (en) | 1984-12-20 |
FR2398718B1 (en) | 1982-10-15 |
ES469953A1 (en) | 1979-09-16 |
FR2398718A1 (en) | 1979-02-23 |
CH643238A5 (en) | 1984-05-30 |
IE780940L (en) | 1978-11-17 |
NL7805344A (en) | 1978-11-21 |
JPH0112744B2 (en) | 1989-03-02 |
DE2821410A1 (en) | 1978-11-30 |
IT1156755B (en) | 1987-02-04 |
NZ187235A (en) | 1981-10-19 |
IT7849419A0 (en) | 1978-05-17 |
FR2401135B1 (en) | 1983-08-19 |
AU8411782A (en) | 1982-08-26 |
AU523496B2 (en) | 1982-07-29 |
FI781490A (en) | 1978-11-18 |
FR2401135A1 (en) | 1979-03-23 |
DK214878A (en) | 1978-11-18 |
JPS53149936A (en) | 1978-12-27 |
AU3606778A (en) | 1979-11-15 |
SE7805591L (en) | 1978-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE443558B (en) | PROCEDURE FOR THE PREPARATION OF AMINOAL REFRIGERATIVE SUBSTANCES WITH PHARMACEUTICAL EFFECT | |
RU2072986C1 (en) | Method of synthesis of carboxylic or sulfonic acid amides or their physiologically compatible salts | |
US5352788A (en) | N-substituted heterocyclic derivatives | |
US4220654A (en) | Cyclic imidazole cyanoguanidines | |
JPH0220639B2 (en) | ||
JPS6056143B2 (en) | Amidine derivatives and their production method | |
SI9210305A (en) | Indole derivatives, processes for their preparation and medicaments containing them | |
HU211463A9 (en) | Propenone oxim ethers, method for preparing them and pharmaceutical compositions containing them | |
GB1604674A (en) | Aminoalkyl-benzene derivatives | |
US5036098A (en) | Butynylamine derivatives and their production | |
PL90695B1 (en) | ||
SE449358B (en) | PROCEDURE FOR THE PREPARATION OF 4-AMINOHEX-5-ACID ACID OR SALTS THEREOF | |
JPS6212788B2 (en) | ||
EP0048555B1 (en) | Amino-1,2,4-triazole derivatives, processes for their preparation and pharmaceutical compositions containing them | |
FI81347C (en) | FRUIT PROTECTION FOR THERAPEUTIC ACTIVATION (PYRROL-1-YL) PHENYLD HYDROPYRIDAZINONER. | |
EP0155653A2 (en) | Substituted (azacycloalk-2-yl) iminophenols and esters thereof | |
EP0335979A1 (en) | Thienopyrimidine derivatives | |
US4523020A (en) | Substituted 2-(3-aminophenoxymethyl)imidazolines | |
US3972994A (en) | Disubstituted azabicycloalkanes | |
US3971814A (en) | Benzo(b)thiophene derivatives | |
US5021429A (en) | Pharmacologically active aminoalkylphenyl compounds and their use | |
EP0029306A1 (en) | Aminoalkyl compounds, their production and pharmaceutical compositions containing them | |
FR2525221A1 (en) | FURANNE DERIVATIVES AND ADDITION SALTS THEREOF, PROCESSES FOR THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS | |
HU193385B (en) | Process for production of derivatives of diamine and medical preparatives consisting of such substances | |
US4599346A (en) | Propan-2-ol derivatives, a process for their production and medicaments containing these compounds |